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TREATMENT OUTCOMES OF THE SUMMER TREATMENT PROGRAM FOR 
CHILDREN WITH ADHD AND COMORBID MENTAL HEALTH DIAGNOSES 
ANTHONY REGIS PIZZUTI 
ABSTRACT 
Although there is substantial support for the efficacy of the Summer Treatment 
Program (Pelham, Gnagy et al., 2010) for children diagnosed with attention deficit 
hyperactivity disorder (ADHD), limited research has evaluated whether children 
diagnosed with additional mental health disorders (comorbidity) show positive outcomes 
and improvements when exposed to an intensive behavior program such as the Summer 
Treatment Program (STP).  Furthermore, there is no research available that shows 
whether children from differing ages or gender who are diagnosed with additional mental 
health disorders (comorbidity) show improvements over the course of treatment.  With 
such limited research, this study investigated a few of the questions raised about the 
treatment outcomes of the STP and whether children diagnosed ADHD, with and without 
comorbid conditions, have positive treatment outcomes and efficacy differences as a 
function of comorbidity, gender and age.  
This particular research study examined archival data from 345 children, aged 6 
to 12 years old, who enrolled in a 7-week Summer Treatment Program from the summers 
of 1999 – 2012.  The dependent variable included the STP point system total weekly 
points earned from the program utilized as the indicator of the rate of change.  A series of 
mixed-effects regression models were computed with the independent measures for age 
group, gender comparisons, and ADHD comorbidity to address four research questions.  
The results of this investigation indicated no significant difference for children diagnosed 
v 
with ADHD alone in treatment outcomes from those children diagnosed with ADHD 
comorbidity.  Both children with ADHD alone and those with ADHD comorbidity made 
treatment gains over the course of the program.  Secondly, significant differences were 
found between males and females diagnosed with ADHD comorbidity regarding 
treatment outcomes, in that females earned significantly more points than males during 
the summer treatment program. Thirdly, there were no significant age group differences 
in treatment outcomes with children diagnosed with ADHD comorbidity.  Lastly, of all 
ADHD comorbid diagnoses, only Oppositional Defiant Disorder (ODD) was significantly 
associated with lower weekly scores than children with a diagnosis of ADHD only.  
The results indicate that treatment matching may reduce some of the clinical 
uncertainty in the literature regarding treatment options for children diagnosed with 
ADHD comorbidity.    
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CHAPTER I 
INTRODUCTION 
ADHD is one of the most prevalent behavioral disorders of childhood in the 
United States and internationally (Tzang, Chang, & Liu, 2009; Visser, Bitsko, Danielson, 
Perou, & Blumberg, 2010).  Roughly an estimated 9.5% of school-aged children are 
affected by ADHD and an additional 3.7% have ADHD combined with a learning 
disability (Center for Disease Control and Prevention [CDC], 2010; Pastor & Reuben, 
2008).  ADHD is a chronic illness that is characterized by abnormally high levels of 
hyperactivity, impulsivity and inattention.  These symptoms are known to severely impair 
many domains of functioning including academic, behavioral, peer relationships, and 
self-esteem.  Often times, these cognitive, behavioral, and social problems in childhood 
tend to be carried on through adolescence and well into adulthood (Barkley, 2003).  
Evolving Concepts of ADHD 
ADHD has been studied for well over the past 100 years; ADHD has taken on 
upwards of 20 various diagnostic labels as descriptors for early childhood mental health 
illnesses.  Few reports were detailed before 1900, but one of the first researchers to 
describe this disorder was Dr. George Still, a pediatrician who depicted young boys as 
having a ‘defect of moral control’ (Still, 1902, p.1008).  He detailed for the first time, a 
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biological link for the unmanageable behavior that these young children had shown as 
noted by their aggression and poor inhibition control (Barkley, 1990).  Still suggested 
that these, mostly 8 year old boys, were considered morally defective with a genetic bias 
toward moral corruption, he believed this moral deficit represented the manifestation of 
some morbid physical condition (Still, 1902, p.1165).  He dismissed cases of poor child 
rearing environments in his research.  Twenty years later, ADHD was referred to as 
“postencephalitic behavior disorder” by Dr. Franklin Ebaugh (1923), named after the 
many children who survived the 1917-1918 encephalitis epidemic.  Ebaugh linked severe 
brain damage with severe behavioral problems and was first to describe the “hyperactive” 
symptoms associated with ADHD today (Barkley, 2007).  
Since Ebaugh’s first description of hyperactive symptoms, the term 
“hyperactivity” changed over time to such terms as, "restlessness," "irritability," and 
"overactivity."  In the late 1930s, Dr. Charles Bradley (1937) accidently discovered the 
effective use of amphetamines and is credited as the first physician to document the 
success of Benzedrine to treat hyperactivity in children.  While caring for children’s 
headaches resulting from painful spinal taps, Bradley found that children’s headaches 
were not particularly affected or relieved by the drug (Bradley, 1950, p. 25).  Instead, 
Benzedrine improved the behavior and school performance of over 30 children, as 
indicated by a stronger interest in school, improved work habits, and reduction in 
disruptive behaviors.  The drug “calmed many of the children without dulling their 
attention span” (Bradley, 1937, p. 578). 
  Calhoun, Greenwell-Iorillo, and Chug (1997) studied the historical 
transformations of the labels and diagnostic categories of ADHD.  They stated that the 
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1940s and 1950s brought new terms describing children with behavior problems; the term 
of choice was ‘distractibility’ by Strauss and Werner (1941) and Strauss and Lehtinen 
(1947).  By the 1950's the labels employed to describe the condition included ‘minimal 
brain damage’ by Strauss and Kephart (1955) (Calhoun, Greenwell-Iorillo & Chug, 1997, 
p. 244).  Another diagnostic category used in the 1950s to describe the condition 
included, "hyperkinetic impulse disorder," (Laufer, Denhoff, & Solomons, 1957, p. 38).  
As a new and specific diagnostic category, they noted, hyperkinetic impulse disorder was 
a behavior pattern that: 
May be noted from early infancy on or not become prominent until five or six 
years of age…Hyperactivity is the most striking item…There are also a short 
attention span and poor powers of concentration, which are particularly noticeable 
under school conditions…The child is impulsive…irritable and explosive, with a 
low frustration tolerance. Poor school work is frequently quite prominent. (p. 38) 
These terms and categories fell out of use during the end of the 1950s and 1960s as 
researchers studied ADHD more closely.  However, during this time, important 
advancements in the use of psychiatric medicines occurred when Methylphenidate or 
Ritalin was introduced in the United States and eventually approved by the Food and 
Drug Administration in 1961 (Swanson, McBurnett, Christian, & Wigal, 1995).  Even 
today, stimulant medications, including Methylphenidate or Ritalin, continue to provide 
benefits for individuals suffering from ADHD (Charach, Ickowicz, & Schachar, 2004).  
In the early 1960s, Chess (1960) studied 82 children who were diagnosed as 
hyperactive out of a total of 881 children seen in her practice. Instead of focusing on 
theories of etiology in her 1960 publication, Chess focused on classification and clinical 
descriptions of hyperactive children. She offered a straightforward definition of 
hyperactivity: “The hyperactive child is one who carries out activities at a higher rate of 
speed than the average child, or who is constantly in motion or both” (Chess, 1960, p. 
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2379).  According to Barkley (1990), Chess was able to differentiate hyperactivity from 
traumatic brain injury; “Chess was significant for her attempt to divide the heterogeneous 
group of hyperactive children into more homogeneous subgroups and for explicitly 
separating the concept of hyperactivity from that of brain injury” (p. 10).  
During the mid1960s, researchers were attempting to discover the definitive link 
between various severities of brain damage and hyperactivity (Herbert, 1964; Rapin, 
1964).  Children and adolescents previously diagnosed with hyperkinetic impulse 
disorder showed no evidence of brain damage (Chess, 1960).  With researchers unable to 
reach a consensus, Barkley (1990) stated that the term, ‘minimal brain damage,’ became 
recognized as “vague, overinclusive, of little or no prescriptive value, and without much 
neurological evidence” (p.10).  ‘Minimal brain damage’ transitioned into a new label 
called, ‘minimal brain dysfunction’ (MBD) which still pointed to central nervous system 
deficiencies, but left little explanation of what the deficiency may be (Clements & Peters, 
1962). 
 When the American Psychiatric Association (APA) offered assistance in 
renaming various disorders during the late 1960s, the term ‘minimal brain dysfunction’ 
was deleted and with the introduction of the Diagnostic and Statistical Manual of Mental 
Disorders-II (American Psychiatric Association, 1968), the new term "hyperkinetic 
reaction of childhood” was added in the DSM-II.  The work of Laufer et al. (1957) and 
Chess (1960) is notable for two important developments.  First, the new criteria allowed 
for classifying hyperactive, impulsive behavior according to a central behavior symptom, 
such as hyperactivity, as well as shifting from the use of diagnostic labels based on 
etiology to taking into account the use of behavioral classification for ADHD.  However, 
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the diagnostic label would not last; “hyperkinetic reaction of childhood disorder” 
provided little useful diagnostic information besides describing hyperactive behavior 
(Barkley, 1990, p. 10). 
From 1980 to 1994, the APA published the third, Diagnostic and Statistical 
Manual of Mental Disorders-III (American Psychiatric Association, 1980) and the fourth, 
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV, American 
Psychiatric Association 1994) publications.  The diagnosis changed from "attention-
deficit disorder" (ADD) and "Attention-deficit disorder with hyperactivity” (ADD-H) to, 
“attention deficit hyperactivity disorder” (AD-HD).  During this time, the APA defined 
three sets of specifiers under the diagnosis of ADHD.  Currently, children diagnosed with 
ADHD fall into one of three specifiers, including predominately inattentive, 
predominately hyperactive, or most commonly, combined type.  
Etiology, Features and Prevalence of ADHD 
 The etiology of ADHD has dodged researchers for decades, but recent studies 
suggest both a strong genetic link as well as biological factors, such as preterm delivery 
and possibly maternal smoking during pregnancy (Biederman, 2005; Milberger, 
Biederman, Faraone, Guite & Tsuang, 1997; Rowland, Lesesne, & Abramowitz, 2002).   
ADHD is a neurobehavioral disorder that typically begins in childhood and is marked by 
developmentally inappropriate problems with attention, organization, and hyperactivity 
that impede the child’s functioning in the family, social, and academic realms (APA, 
2000).  DSM-IV delineates three subtypes of ADHD: (a) ADHD, combined type 
(ADHD-C), encompassing persistent symptoms of inattention and hyperactivity; (b) 
ADHD, predominately inattentive type (ADHD-I) referring to children (or adults) who 
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meet the diagnostic criteria for inattention but not hyperactivity; and (c) ADHD, 
predominately hyperactive-impulsive type (ADHD-HI) denoting individuals who meet 
the criteria for hyperactivity and impulsivity but not inattention.  Of the three subtypes, 
the ADHD-HI is the least prevalent (Tzang et al., 2009). 
More than twice as many boys as girls are diagnosed with ADHD (Pastor & 
Reuben, 2008).  Between 1997 and 2006, there was a 4% increase in the number of girls 
diagnosed with ADHD in the U.S. versus a 2% increase in boys, which may signify 
increasing sensitivity to ADHD in girls.  Some studies reported that girls are more likely 
to have the inattentions subtype, which is less overt, which could lead to misdiagnosis or 
under-diagnosis in girls.  However, other studies reported similar proportions of boys and 
girls with the ADHD combined and predominately inattention subtypes (Tzang et al., 
2009). ADHD with comorbid LD was roughly twice as common in boys (Pastor & 
Reuben, 2008). 
Gender is the most predictable factor in the demographic distribution of ADHD in 
the general population.  The only reported ethnic variation in ADHD in the American 
population is that the prevalence is lower in Latino families.  According to the 2004-2006 
National Health Interview Survey (NHIS), Latino children were less likely to be 
diagnosed with ADHD than white or black children (Pastor & Reuben, 2008).  However, 
2007 data from the CDC’s National Center for Health Statistics revealed increases in 
ADHD among Latino children though the prevalence was still lower for Latino children 
than for other ethnic groups (Visser et al., 2010).  The CDC researchers proposed that the 
increase might reflect more acceptance of the ADHD diagnosis by Latino families, better 
access to health care, or a combination of both. 
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The role of socioeconomic status (SES) in ADHD prevalence is less consistent.  
According to the NHIS, ADHD without LD was most common in children whose 
mothers had completed high school but not college though older children with only 
ADHD tended to have the most educated mothers (Pastor & Reuben, 2008).  ADHD 
combined with LD was most prevalent in children with the least educated mothers and 
also in families headed by single mothers.  Diagnosed ADHD is more common in 
families with health insurance but the critical factor seems to be access to health care 
rather than SES; ADHD diagnoses are equally common in children with private insurance 
and Medicaid.  Treatment with stimulant medication alone seems to be more prevalent 
among low-income children in the U.S. and Canada, under very different health care 
systems (Ter-Stepanian, Grizenko, Zappitelli, & Joober, 2010). 
National surveys consistently report that the financial cost of ADHD carries a 
heavy burden for families, schools, and the health care system (Pastor & Reuben, 2008).  
A 2006 estimate placed the number of school-aged children (aged 5-17 years) with 
diagnosed ADHD at 4.5 million.  Schools report that the number of children with ADHD 
in special education programs is rapidly increasing.  According to parents’ reports, there 
was a gradual but decisive increase in the number of children with ADHD between 2003 
and 2007 (Visser et al., 2010).  Apart from financial cost, untreated or inadequately 
treated ADHD has serious human cost.  ADHD interferes with academic achievement 
and children with ADHD and comorbid conduct disorder (CD) are at high risk for 
adolescent delinquent behavior and substance abuse (Molina et al., 2009).  Young and 
Amarasinghe (2010) emphasized that ADHD is a developmental disorder beginning in 
early childhood and persisting into adulthood.  Most research on ADHD has focused on 
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school-age children.  Young and Amarasinghe advocated for multimodal interventions 
specially tailored to each developmental stage from preschool through adulthood. 
Family Influences 
ADHD is generally recognized as having genetic and environmental components, 
though there is some disagreement on the magnitude of each respective influence.  Some 
may infer that because ADHD has biological roots, parents and families do not play a 
role in the etiology, management, or treatment, therefore medication should be the 
foremost treatment modality (Howe, 2010).  From most perspectives, however, the 
environment is extremely important in the expression of ADHD symptoms and 
behaviors.  Behavior modification centers on altering the child’s environment, which 
cannot be accomplished without the efforts of parents, teachers, or other significant adults 
in the natural environment.   
Researchers studying ADHD, point to the diathesis-stress model (Brown & 
Barlow, 1997; Monroe & Simons, 1991;Zuckerman, 1999) which suggested that some 
persons can be more vulnerable than others to stressful environmental influences, which 
then influences one’s psychopathology.  Similarly, the diathesis-stress model of ADHD, 
suggested that families, schools, and peer groups that display negative and punitive 
attitudes toward inattention, impulsivity, and hyperactivity and offer minimal support for 
the development of self-regulation skills are likely to perpetuate or intensify symptoms of 
ADHD in vulnerable children (Carr, 1999).  On the other hand, social systems that are 
more accepting of inattention, impulsivity, and hyperactivity and offer opportunities for 
building self-regulation skills are more likely to help biologically vulnerable children 
develop self-discipline and control. Several key assumptions underlie the diathesis-stress 
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model.  In the context of families, the model proposed that families struggling to deal 
with multiple stressors with minimal social support and poor quality of life may use 
parenting styles and patterns of family interaction that adversely affect children who are 
vulnerable to ADHD.  In addition, parents with this profile often have childhood histories 
of ADHD symptoms.  They may experience psychological distress as a result of caring 
for a child with ADHD (Harpin 2005). 
Lange et al. (2005) examined the family factors that are associated with attention 
deficit hyperactivity disorder and emotional disorders in children and questions whether 
parents of children with other behavioral or emotional disorders report problems similar 
to parents of children with ADHD.  To examine these issues, Lange et al. (2005) 
compared parents of children with ADHD with parents of children with other emotional 
disorders (such as depression or anxiety) and a control group of parents of children with 
no emotional or behavioral disorders.  The participants were 22 mothers and 13 fathers of 
22 boys who scored above 63 for externalizing behaviors on the Child Behavior 
Checklist (Achenbach, 1991) and had a DSM-IV diagnosis of ADHD, 20 mothers and 15 
fathers of 20 boys with high scores for internalizing behaviors on the CBCL and 
diagnosis of major depression, dysthymia, or an anxiety disorder, and 26 mothers and 16 
fathers of 17 control group boys. 
The parents were also assessed on family life events, perceived social support, 
quality of life, family functioning, parenting styles, parenting satisfaction, general health, 
and their perceptions of ADHD symptoms in their own childhood.  As Lange et al. 
(2005) expected, the two groups of parents whose children had ADHD or emotional 
disorders reported higher levels of stress, lower social support, and decreased quality of 
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life compared to the control group parents.  Furthermore, the parents of children with 
clinical diagnoses experienced more family stress.  However, there were no notable 
differences in the problems reported by the parents of children with ADHD and 
emotional disorders.  One distinction in parenting style was that the parents of children 
with ADHD were more predisposed toward authoritarian parenting (Lange et al., 2005).  
As anticipated, the parents of the two clinical groups of children reported lower parenting 
satisfaction compared to the control group parents.  Overall, the findings were essentially 
consistent with prior research on the psychosocial factors associated with ADHD and 
supported the diathesis-stress hypotheses.  The most notable finding was the striking 
similarity in the psychosocial profiles of families of children with ADHD and emotional 
disorders. 
Perhaps those similarities should not be surprising in view of the extent of ADHD 
comorbidity.  Efron and Sciberras (2010) reported that among 64 children ranging in age 
from 4 to 9 years who were referred to a children’s hospital for evaluation in response to 
suspected ADHD, one-third actually had a different primary diagnosis and three-quarters 
of the children had one or more comorbid disorders.  Although the figure for comorbity is 
high, it is not extraordinary.  As in most studies, the most common comorbid disorders 
were ODD and LD.  Given the high prevalence of comorbidity and the complex and 
multifaceted nature of symptom profiles and psychosocial assessments, it would virtually 
be impossible to treat ADHD with medication alone and without enlisting families as 
active partners in treatment.  Family stress only works to sustain or exacerbate ADHD.  
In fact, parent behavior training programs for children with emotional and behavioral 
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disorders have strong empirical support (Pelham & Fabiano, 2001, 2008; Pelham & 
Gnagy, 1999; Young & Amarasinghe (2010).     
Drabick, Gadow, and Sprafkin (2006) examined the coexistence of conduct 
disorder (CD) and depression in boys with ADHD who were evaluated in the diagnostic 
stage of a research project on boys with emotional and behavioral disorders.  The 248 
boys, aged 6 to 10, were recruited from several sources including a child psychiatry 
outpatient clinic, an ADHD parent support group, as well as referred by parents, schools, 
or other professionals.  A number of psychosocial factors emerged as predictors for the 
development or escalation of conduct problems in children with ADHD.  In particular, 
harsh, detached, and inconsistent parenting practices were associated with CD.  A family 
milieu marked with low family cohesion, high conflict, and low marital satisfaction 
predicted both CD and depression.  Finally, social problems were linked with depression.  
Drabick et al. noted that these relationships held regardless of whether the child’s 
behavior was reported by a parent or teacher.   
According to Drabick et al. (2006), their findings support the theory of shared risk 
factors for ADHD and Conduct Disorder comorbity.  In accordance with coercion theory, 
parenting behaviors reflecting hostility, inconsistent discipline, and detachment from the 
child predicted CD symptoms in the group of boys whose ADHD was reported by 
mothers and CD and depressive symptoms in the teacher-described group.  Low marital 
satisfaction and low family cohesion were associated with depression, CD, and parenting 
behaviors.  The one finding that contrasted with the researchers’ expectations was that 
academic and cognitive functioning were not associated with depression, although 
Drabick et al. (2006) acknowledged that an earlier study by Biederman and colleagues 
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also found no relationship between ADHD and school problems and depressive 
symptoms.    
Deault (2010) conducted a review of empirical literature from 2000-2008 
examining parenting factors related to children’s ADHD, with particular emphasis on the 
development of comorbid internalizing and externalizing problems and functional 
impairments in the academic and social environment.  A total of 22 studies (18 
correlational studies and 4 longitudinal studies) met Deault’s inclusion criteria.  The 
overall findings indicated that ODD rather than ADHD was more closely linked with 
negative parenting practices and family conflict.  Factors potentially linked with 
oppositional and conduct problems in children with ADHD included parental ADHD, 
maternal depression, limited positive parent involvement, and family conflict.  However, 
the specific patterns among these factors, in relation to behavior problems, are uncertain. 
More recently, comorbidity with ADHD has stepped to the front as one of the 
most important aspects of this pervasive disorder (Brown, 2000; Jensen et al., 2001a, 
2001b). Typically, rates of comorbidity with ADHD are high with boys presenting with 
higher rates of ADHD than girls. According to, The Agency for Health Care Policy and 
Research (AHCPR, 1999), a stronger presence of the externalizing disruptive behaviors 
are reported with almost one third of children diagnosed with ADHD also being 
diagnosed with oppositional defiant disorder (ODD) and one fourth of children diagnosed 
with ADHD qualifying for a diagnosis of conduct disorder (CD). Overall, there are fewer 
children diagnosed with internalizing disorders (depressive and anxiety) co-occurring 
with ADHD than children diagnosed with externalizing problems (Oppositional Defiant 
Disorder and Conduct Disorder) with ADHD. Less than one-fifth of children diagnosed 
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with ADHD also present with a depressive disorder while more than one-fourth of 
children diagnosed with ADHD have an additional anxiety disorder. Remarkably, almost 
one-third of children diagnosed with ADHD also have more than one comorbid 
condition. Overall, comorbid conditions range from 12.36% (learning disorders) to 
35.15% (conduct disorder) in children.  By definition, children diagnosed with ADHD 
and a comorbid diagnosis will have substantial difficulties in many areas, owing to 
increased psychopathology, necessitating treatment comprehensiveness for intervention 
in all impaired domains (AHCPR, 1999).  
Various psychosocial and other treatments have been undertaken and are widely 
practiced interventions for ADHD, including traditional in-office psychotherapy, play 
therapy, vitamins, restrictive diets, biofeedback, chiropractic care, perceptual motor 
training, inner ear treatment, and pet therapy, among others. However, none of these 
therapies have shown empirical support in successfully treating ADHD (Pelham & 
Gnagy, 1999). Alternately, to improve daily living, treatments with sustained, intensive, 
and comprehensive behavioral interventions are recommended and supported (Chronis, 
Jones, & Raggi, 2006; Pelham & Gnagy, 1999). Although a number of treatment options 
are available to parents of children diagnosed with attention-deficit/hyperactivity 
disorder, Pelham and Gnagy (1999) stated only three approaches have been supported by 
empirical data and research, including, “1) behavior modification,  2) central nervous 
stimulants and 3) the combination of both” (p.225).  Each of these three interventions has 
shown effectiveness in the short term; however, no treatments have been promising to 
positively impact adolescent or adult outcomes (Owens et al., 2003; Pelham & Gnagy, 
1999). 
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The only form of psychosocial treatment with demonstrated efficacy is behavioral 
interventions for children suffering with ADHD. Behavioral treatments have been used 
for children specifically diagnosed with ADHD for numerous years and have been used 
to treat children variously described as aggressive, disruptive, or diagnosed with conduct 
disorder (Pelham & Gnagy, 1999). Epidemiological studies and clinical studies of 
comorbidity have suggested that the majority of children described as 
disruptive/aggressive in early studies would have been diagnosed with ADHD (with or 
without comorbid aggression, conduct disorder, or oppositional defiant disorder) had 
DSM criteria been used (Gillberg, Gillberg, Rasmussen, Kadesjo, Soderstrom, & 
Rastram, 2004). Thus, there is extensive literature on behavior treatments for ADHD, 
covering hundreds of studies and thousands of children (Brestan & Eyberg (1998), 
Eyberg, Nelson, & Boggs (2008); Pelham, Greiner & Gnagy., 1998; Wells et al., 2000a) 
Researching behavioral treatments, or behavior modification, for children 
diagnosed with ADHD is accompanied with challenges that are not shared readily by 
research about medication management. For example, since behavioral treatment 
involves changing the environment around the child (i.e., external management), 
generalization of treatment effects to other environments (e.g., home, academic) is 
dependent upon application of similar contingencies within these other settings. This is 
different than medication management research, in which changes to the neurological 
functioning of the child’s brain (e.g. internal management) is attained. Pharmacological 
research, therefore, is less susceptible to problems of generalization of treatment effects 
than behavioral research (e.g., with medication, if effective dose is identified, then effects 
tend not to vary as a function of the child’s setting).  
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 Pelham and Gnagy (1999) found outpatient behavioral treatments or what they 
called clinical behavior therapy, has a number of additional challenges. In many ways, 
clinical behavioral therapy has limitations similar to those of central nervous system 
stimulant medication. First, although children receiving clinical behavioral therapy 
interventions improved greatly, “they are less likely than the active medication group to 
normalize children on parent and teacher rating scales and large minorities of children 
fail to show improvements with clinical behavioral therapy” (Pelham & Gnagy, 1999, p. 
230). Although moving to a cost-reward system would in many cases dramatically 
increase improvements, some parents and teachers are unable or unwilling to implement 
complicated behavioral interventions. Even when parents and teachers are willing to 
initiate comprehensive interventions, they typically do not continue them without 
ongoing consultation. Furthermore, there is a lack of evidence of long term effects of 
behavior therapy for children with ADHD similar to psychostimulant medication (Pelham 
& Gnagy, 1999). Overall, demonstration of the continuation and/or maintenance of 
treatment effects over time is one of the major concerns of those using behavioral 
interventions with children. Research regarding how to maintain effects in the long run 
has not been undertaken. Again, these limitations have led to a growing practice of using 
a combination of treatments, medications, and behavioral treatments.  
One study of particular interest (also discussed in chapter 2) that has examined the 
effectiveness of using a combination of treatments (medications and behavior therapy) is 
the Multimodal Treatment Study of Children with ADHD (MTA Cooperative Group, 
1999a; Arnold et al., 1997a, 1997b; Richters et al., 1995), which is one of the largest 
NIMH funded research projects conducted, regardless of diagnosis. The MTA assessed 
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the adequacy of 4 treatment groups in decreasing ADHD symptomatology, namely 1) 
standardized, careful medication management only (Jensen et al., 2001b; Vitiello et al., 
2001; Greenhill et al., 1996), 2) standardized and manualized behavioral management 
only (Wells et al., 2000a; Pelham, 2000; Pelham et al., 1998), 3) a combination of the 
two, and 4) standard community care. Initial results reported by the MTA Cooperative 
Group (Jensen et al., 2001a) clearly pointed out the superiority of medication 
management only over all other groups. 
However, a number of follow-up analyses have provided a better picture of which 
approach may work best for whom, especially when considering the potential moderators 
and mediators of treatment responses (Owens et al., 2003; Wells et al., 2000b; MTA 
Cooperative Group, 1999b). The specific aspects of the family, parent, or child 
demonstrated to have an impact on response to treatment include parental compliance and 
adherence with the treatment and family stress variables (Hinshaw et al., 2000), parent 
cognitions (Hoza et al., 2000), SES (Rieppi et al., 2002), severity (Swanson et al., 2001a, 
2001b), and comorbidity (Jensen, 2001a). Additionally, a combined treatment approach is 
typically what most pediatricians recommend for most children and adolescents. In fact, 
the American Academy of Pediatrics (2001) has issued guidelines for the treatment of 
ADHD and a combined treatment approach is strongly recommended. 
Much of the information that the American Academy of Pediatrics used to create 
proposed guidelines was interpreted from information that was generated by the MTA 
Cooperative Group. It can be argued that children diagnosed with ADHD and comorbid 
conditions would have a need for more intensive interventions due to their multiple 
impairments; a combined treatment approach is urgently needed. Therefore, treatment 
17 
must be implemented at home and school, and/or any location where the child may show 
impairment. Identifying a comprehensive intervention program which treats ADHD and 
comorbidity, regardless of whether the problems are co-occurring internalizing or 
externalizing disorders, remains of substantial interest to researchers.   
One particular intensive behavioral intervention that uses a combined treatment 
approach that merits attention for treating children diagnosed with ADHD is the Summer 
Treatment Program (STP), a comprehensive day treatment program. To date, much of the 
research focused on the Summer Treatment Program has been conducted by Pelham et 
al., (2010). The STP was a critical component of the MTA behavioral management-only 
group and has been recognized as a model treatment program for ADHD by the National 
Institute of Mental Health for well over 20 years (Pelham & Hoza, 1996; Pelham et al., 
1998). The intensive Summer Treatment Program combines the structure of the school-
year with an outpatient follow-up program to provide a maximally effective psychosocial 
intervention for ADHD (Chronis et al., 2004; Pelham & Hoza, 1996). Yet to date, no 
research has fully addressed the potential effectiveness of such an intensive behavior 
program with children diagnosed with ADHD and comorbid conditions. Therefore, the 
purpose of this dissertation was to examine whether or not the Summer Treatment 
Program effectively treats children diagnosed with ADHD and a comorbid condition.  
Research Questions 
The purpose of this dissertation is to answer the following research questions: 
• Do children diagnosed with ADHD alone, who attend an intensive 
summer treatment program, differ in treatment outcomes from those 
children diagnosed with ADHD and a comorbid diagnosis? 
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• Do males diagnosed with ADHD and a comorbid diagnosis, who attend an 
intensive summer treatment program, differ in treatment outcomes from 
females with ADHD comorbidity? 
• Are there age group differences in treatment outcomes with children 
diagnosed with ADHD and a comorbid diagnosis who attend an intensive 
summer treatment program?   
• Do children with different comorbid diagnoses and ADHD, who attend an 
intensive summer treatment program, differ in treatment outcomes?  
To begin to answer these research questions, a review of literature was conducted.  
Chapter Two provides a look at treatments for ADHD and comorbidity, including 
information about: ADHD and comorbid learning disorders, ADHD related to gender and 
comorbidity studies, and the MTA Cooperative Group, comorbid subgroups studies, 
alternative intervention programs and the summer treatment program 
Conclusion 
In conclusion, this chapter outlined the historic and clinical foundations of this 
dissertation research. Highlighting the foundational studies led to the next research step 
of examining the efficacy of the Summer Treatment Program. The research questions 
were formed from the identification of the need for further research about treatments with 
children diagnosed with ADHD and a comorbid condition.  A detailed examination of the 
relevant literature follows in Chapter Two.
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CHAPTER II 
LITERATURE REVIEW 
This chapter reviews relevant literature, including studies’ descriptions and 
analyses, to highlight some of the comparable research relating to this current 
dissertation. Sections in this chapter include discussions of both contributions and 
limitations, concerning the topic of treatment for ADHD and comorbidity, including 
information about: ADHD and comorbid learning disorders, ADHD relating to gender 
and comorbidity studies, and the Multimodal Treatment Study of Children with ADHD 
MTA Cooperative Group, comorbid subgroups studies, alternative intervention programs 
and the summer treatment program.  The studies discussed in this chapter lead to a better 
understanding of how this dissertation research contributes a next step in the vast 
literature about ADHD. 
Since the 1980s there has been an increase in the number of U.S. children 
diagnosed with behavioral and learning disorders (Pastor & Reuben, 2008).  Increases in 
diagnoses of ADHD cross all socio-demographic lines (Visser et al., 2010).  The growing 
numbers of children with behavioral and learning disorders have been met with an 
expansion of programs and services for children and adolescents. 
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Children diagnosed with ADHD often rely on stimulant medication as their only 
form of treatment.  However, major professional organizations are virtually unanimous in 
endorsing the merits of combined medication and behavior therapy (Waschbush, Carrey, 
Willoughby, King, & Andrade, 2007).  In 1987, the American Academy of Pediatrics 
(AAP) restated their earlier position that “Medication for children with attention deficit 
disorder should never be used as an isolated treatment,” and went on to describe several 
strategies for treating children with ADHD, such as behavior modification, physical 
education programs, and “the provision of structure,” in fact recommending that these 
strategies should be tried before resorting to medication (AAP, cited in Hoffman, 2009, p. 
33).  Stimulant medications have since become the first line treatment for ADHD.  At the 
same time, there is an accumulating evidence base on psychosocial interventions that are 
effective for ADHD (Pelham & Fabiano, 2008).   
Hoffman (2009) attributed the shift in thinking from behavioral interventions to 
reliance on medication to the publication of the Multimodal Treatment Study of Children 
with ADHD (MTA) in 1999.  Studies reporting findings from the MTA are included in 
this chapter (Karpenko, Owens, Evangelista, & Dodds, 2009; MTA Cooperative Group, 
2004a, 2004b; Molina et al., 2009; Owens et al., 2003).  The more recent research 
findings support the assertion that medication is insufficient and that there is a need for a 
variety of available treatment options.  Pelham and Fabiano (2008) emphasized that 
ADHD is a chronic condition and treatment must be both intensive and ongoing.  In fact, 
Coles et al. (2005) argued that the inconsistent results of behavioral treatments for ADHD 
may be attributed to the general reliance on non-intensive interventions. 
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Pelham and Fabiano (2008) and Coles et al. (2005) conducted extensive research 
on the Summer Treatment Program (STP), detailing the variety of behavioral treatments 
in a unique atmosphere of combining recreational and academic activities.  Prosocial 
behavior was continually rewarded and reinforced by program staff.  The STP is also the 
focus of this dissertation. 
Many of the children who participated in the STP were diagnosed with ADHD 
with one or more comorbid disorders, which affected their treatment responses (Coles et 
al., 2005).  In fact, comorbidity in ADHD is rampant, especially a diagnosis including 
ODD (Barnett, Maruff, & Vance, 2008; Efron & Sciberras, 2010; Howe, 2010; Martel, 
Gremillion, Roberts, von Eye, & Nigg, 2010; Qian, Cao, Chan, & Wang, 2006).  
Children diagnosed with ADHD are also at elevated risk for developing conduct disorder 
(Drabick, Gadow, & Sprafkin, 2006).  Learning disabilities are also prevalent among 
children with ADHD (Jakobson & Kikas, 2002; Miranda, Soriano, Fernandez, Melia, 
2008; Pastor & Reuben, 2008; Pelham & Fabiano, 2011).  Many children diagnosed with 
ADHD also have depression and anxiety in conjunction with externalizing behavior 
problems.  Further complicating the accurate assessment and treatment of ADHD is the 
fact that the symptoms of the coexisting disorders overlap considerably with the 
symptoms of ADHD (Rowland, Lesesne, & Abramowitz, 2002). 
According to Pelham and Fabiano (2001), the pivotal factor in successfully 
treating children diagnosed with ADHD and comorbid conditions is not the diagnosis, per 
se, but rather the impairment associated with the comorbid conditions.  They emphasized 
that ADHD is not solely defined by symptoms; impairment in functioning is typically the 
cause of referrals for evaluation and should be the focus of treatment.  Karpenko et al. 
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(2009) addressed the question of whether clinically significant changes in the symptoms 
of ADHD and ODD translate into reliable improvement in psychosocial functioning.   
One glaring gap in the research literature is the lack of attention to girls diagnosed 
with ADHD (Elkins et al., 2011; Lee & Hinshaw, 2006; Marks, Nichols, Blasey, Kato, & 
Huffman, 2002; Monteaux, Mick, Faraone, & Biederman, 2010; Pelham & Fabiano, 
2008; Zalecki & Hinshaw, 2004).  There is some evidence of a “gender paradox;” that is, 
when a disorder is more common in one gender, it may have more negative ramifications 
for the gender in which it is less prevalent (Elkins et al., 2011).  However, it is impossible 
to ascertain whether that is accurate for ADHD without sufficient research on ADHD 
diagnoses in girls.  Many studies have included only boys and examined individual 
variations, which are substantial in the case of ADHD.  Beyond gender comparisons, 
there is a need for further investigation of individual differences among girls, including 
the etiology, manifestations, and treatment of comorbid disorders. 
Gender, ADHD and Comorbidity 
Rydell (2010) investigated family factors as features related to ADHD and ODD 
in a community sample drawn from two areas of Sweden.  The random sample of 1,206 
10-year old children was 52% male, with the overwhelming majority (93%) of the 
children having at least one sibling.  Most of the children lived with both biological 
parents, whose educational level was fairly high.  In addition to sociodemographic 
attributes and ADHD and ODD symptomology derived from DSM-IV criteria, the 
parents were queried about negative life events affecting the child and the family. 
Sociodemographically, the children living in single or stepparent families, whose 
mothers had low educational level, and whose families were non-European heritage were 
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more likely to display high levels of ADHD and ODD symptoms (Rydell, 2010).  It is 
questionable whether the effect of ethnicity, which was specifically linked with ODD, is 
applicable to the much more diverse U.S. society.  Most of the non-Europeans were 
immigrant families from the Middle East and many were refugees, which heightens the 
stress of immigration.  ADHD was strongly linked with residing in a single parent or 
stepparent family. 
A notable finding was that adverse life events, especially family conflicts, 
increased the risk of ADHD and ODD above the effects of sociodemographic factors, but 
sociodemographic factors had minimal moderating effects on adverse life events (Rydell, 
2010).  Boys appeared to be more vulnerable to stress than girls.  In view of the strong 
biogenetic component of ADHD, Rydell had expected sociodemographic factors to have 
less of an effect on ADHD than ODD; however, that was not the case.  To Rydell, the 
most striking finding was the powerful impact of family stress on the development of 
disruptive behavior disorders. 
Rydell (2010) observed that teachers, but not necessarily parents, tended to report 
a higher prevalence of ODD symptoms in boys compared to girls. Derks, Dolan, 
Hudziak, Neale, and Boomsma (2007) questioned whether gender differences in the 
prevalence of ADHD and ODD might reflect measurement bias.  They also examined 
prospective gender differences in the genetic and environmental influences on the two 
behavior disorders.  The study was part of an ongoing research project on development 
and psychopathology involving twins from the Netherlands Twin Registry.  The twins 
were all from a 1992-1996 birth cohort considered nationally representative at age 3 
based on their Child Behavior Checklist (Achenbach, 1991) scores and were later 
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assessed by their teachers at age 7 using the Conners Teacher Rating Scale-Revised: 
Short Version (Conners, 2001).  The sample was composed of 800 male and 851 female 
7-year old twins. 
The teachers’ assessments of ADHD and ODD behaviors were consistent for boys 
and girls, thus showing no indication of bias.  Derks et al. (2007) interpreted this finding 
as evidence that boys are more susceptible to ADHD and ODD than girls.  For boys and 
girls more than half the variation in ADHD and ODD was attributable to genetic factors.  
However, different genes seem to play a role in the gene expression of ADHD and ODD 
in each gender.  The study did not explore specific environmental influences on behavior, 
except to conclude that the variation in ADHD and ODD, which is not accounted for by 
genetic factors, was attributable to unique environmental influences. 
Marks et al. (2002) examined behavior problems associated with ADHD 
comorbidity in 40 girls diagnosed with ADHD, with 55 boys as a comparison group.  
Drawn from children who had been evaluated at a Northern California community 
behavioral health center, the children had a mean age of about 9 years and were primarily 
white or Latina/o.  In addition to DSM-IV or DSM-III-R diagnostic tests, the children 
were assessed using the CBCL.  There were no significant differences in ADHD subtypes 
based on gender.  Consistent with the ADHD diagnosis, the girls were rated by their 
parents as exhibiting clinically significant levels of attention difficulties, regardless of a 
concurrent problem.  However, different behavior patterns were found between the girls 
diagnosed only with ADHD or had ADHD with comorbid Axis I disorders and those who 
had ADHD diagnoses in combination with LD. 
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Apart from inattention, the girls diagnosed with ADHD and LD had few 
behavioral problems (Marks et al., 2002).  Compared to that group, the girls with only 
ADHD had significantly elevated scores on the subscales of Delinquent Behavior and 
Somatic Complaints and the girls with ADHD and Axis I disorders were assessed by their 
parents as displaying more aggressive behavior and somatic complaints.  Marks et al. 
noted that actually the girls’ scores on the Somatic Complaints subscale were relatively 
low compared to other dimensions, but it served the purpose of distinguishing the three 
groups of girls: ADHD only, ADHD with Axis I disorders, and ADHD and LD, in 
particular the first two groups from the girls with ADHD and LD.  Among the boys 
diagnosed with ADHD, those with ADHD and LD also had evidence of behavior 
problems, which is consistent with most research findings. 
 Monteaux et al. (2010) investigated the role of gender in the trajectory of ADHD 
and comorbid conditions from childhood to adolescence.  The participants came from 
two longitudinal family studies conducted in Massachusetts.  The first study started in the 
late 1980s with families who had one boy with ADHD and a male sibling without ADHD 
between the ages of 6 and 17 at the onset of the study.  The participants were assessed at 
4-year and 10-year follow-ups.  The second study, using the identical design, involved 
girls with ADHD and their female siblings.  Monteux et al. combined the data from both 
studies, with a total sample of 471 participants with ADHD and a mean age of 11.5 at the 
baseline assessment. 
For both male and female participants, Monteux et al. (2010) observed a decline 
in ADHD symptoms over time, which is commonly reported.  However, gender 
differences emerged in the effects of age on comorbid conditions.  Among the girls, 
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psychiatric comorbid diagnoses were relatively stable from childhood to adolescence, 
compared to their male counterparts.  Additionally, childhood and adolescent ADHD 
comorbidity were not associated with adolescent comorbidity among the males, but 
among the females, the stability of comorbidity retained its significance even after 
accounting for the association between childhood comorbidity and ADHD.  In both 
childhood and adolescence, the girls displayed significantly higher levels of severity of 
ADHD than the boys, providing some support for the gender paradox.  However, 
Monteux et al. added that while the difference was statistically significant, it was small 
and minimally clinically significant.  At the same time, they stated that this finding 
warrants additional research. 
Comorbid psychopathology in childhood was a significant predictor of future 
comorbidity in adolescence.  However, the differences in the patterns they found in the 
male and female participants led Monteaux et al. (2010) to suggest that for males with 
ADHD, the persistence of comorbidity in adolescence may be more contingent on the 
severity and persistence of ADHD per se, while for females comorbidity in adolescence 
may be more of a result of both the persistence of ADHD and the comorbid condition.  
Their findings led the researchers to conclude that gender plays a critical role in the 
trajectory of ADHD and concurrent psychiatric conditions. 
Academic Performance 
 Biederman et al. (2004) examined the impact of ADHD and deficits in executive 
function on children’s academic performance using data drawn from two identically 
designed family studies of ADHD.  The two studies involved children and adolescents 
with or without ADHD between the ages of 6 and 17 at the time of the intake assessment.  
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The second assessment was four years later.  The data analysis included 121 male 
proband (individual or member of the family being studied)  participants diagnosed with 
ADHD, 103 male control group participants, 138 female proband participants, and 122 
female control group participants.  The children were given a battery of psychiatric, 
psychosocial, cognitive, and neuropsychological assessments. 
As predicted, the children and adolescents with ADHD had a higher incidence of 
executive function deficits than their control group peers (Biederman et al., 2004).  In 
addition, among the participants with ADHD, executive function deficits increased the 
risk for LD, grade retention, and lower academic achievement.  The analyses also showed 
that the children and adolescents diagnosed with ADHD and executive function deficits 
came from lower SES families than those with ADHD but no executive function deficits.  
This finding is consistent with the higher prevalence of concurrent ADHD and LD in 
children whose mothers have limited education (Pastor & Reuben, 2008). 
Learning Disabilities 
Miranda et al. (2008) investigated the impact of age and LD with 67 boys and 5 
girls with ADHD.  Most were from low SES families.  The children were divided into 
four groups based on LD status and age: 6-9 years and 10-14 years.  The children were 
assessed with the Conners' Teacher Rating Scales–Revised: Long (Conners et al., 1998) 
and the Strengths and Difficulties Questionnaire (Goodman, 1997).  Parents and teachers 
both served as behavioral raters.  It is not unusual for parents and teachers to diverge in 
their ratings of children’s behaviors.  There was more congruence between parents and 
teachers regarding externalizing behaviors which are more persistent, severe, and overt.  
On the more subtle internalizing symptoms of anxiety, emotional liability, and emotional 
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problems there was limited agreement between parents and teachers.  There is always the 
question of whether parents and teachers have different subjective judgments or children 
behave differently at home and at school.  Both explanations may account for some 
degree of discordant ratings. 
The children diagnosed with ADHD and LD had more psychological problems 
than those with ADHD alone (Miranda et al., 2008).   Based on the teachers’ appraisals, 
the older children with ADHD had more psychological problems than their younger 
counterparts.  According to the researchers, the older children may have had unsuccessful 
interventions in the past and their symptoms might have escalated.  Alternately, there are 
more academic demands on children in the higher grades and problems such as 
inattention and lack of organization and planning present more of an impediment 
academically.  Overall, the group with the highest level of problems was the younger 
children with ADHD and LD.     
Jakobson and Kikas (2007) examined cognitive functioning in children with and 
without ADHD diagnoses, with and without LD.  The participants were 152 children 
ranging in age from 7 to 10 years who were tested individually in private, quiet rooms in 
psychiatric hospitals for the clinical group and at school for the non-clinical group.  All 
the children diagnosed with ADHD had the combined type.  There was only one girl in 
each of the two clinical groups (ADHD-C plus LD or ADHD-C without LD).  Each child 
was individually matched on age and gender with a control group child. 
The study was conducted by researchers at the University of Tartu in Estonia who 
created the tests for the purpose of their study (Jakobson & Kikas, 2007).  The children 
were presented with five tests of visual-spatial skills, including working memory tasks, 
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both verbal and visual-spatial, two tasks to test fine motor skills, and four tests of verbal 
ability.  The children with ADHD-C, with or without LD, experienced difficulties 
performing tasks that demanded complex cognitive organization.  Their ability to process 
visual information was substantially lower than the control group, though the children 
diagnosed with ADHD alone performed better than those with ADHD and LD.  On the 
working memory tests, the two groups of children diagnosed with ADHD also performed 
lower than the control group but comparably with one another.  Jakobson and Kikas 
(2007) suggested that poor problem solving skills might have caused the lower 
performance. 
Having a task that was more concrete was helpful for the children with ADHD 
alone but not for the children diagnosed with ADHD and LD (Jakobson & Kikas, 2007).  
The only task on which ADHD did not impede performance was a fine motor task that 
demanded speed rather than accuracy.  On the motor task that demanded coordination, 
both groups of children diagnosed with ADHD had difficulty, with some slight advantage 
for the children with ADHD and LD.  Jakobson and Kikas used discriminant function 
analysis to determine if the tests could distinguish the children with ADHD-C and LD 
and ADHD-C without LD.  The tests accurately classified 73.6% of the children.  When 
the results of cognitive, academic, and psychosocial assessments of children with ADHD 
were examined together, it seems improbable that medication could sufficiently address 
the multiple impairments they experienced without psychosocial intervention. 
Gender and Psychosocial Competence   
Thorell and Rydell (2008) explored the associations between social competence 
and behavior problems and children’s gender and age in preschool and school-age 
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children.  Social competence was assessed using the Social Competence Inventory 
(Rydell, Hagekull, & Bohlin, 1997).  The SCI has two subscales measuring prosocial 
orientation (ability to engage in positive peer interactions) and social initiative (ability to 
initiate and participate in social interactions).  The Strengths and Difficulties 
Questionnaire (Goodman, 1997) was utilized to assess negative impact on the child’s 
everyday life and family burden related to behavioral and emotional problems.  The 
sample was comprised of 60 children who scored high on ADHD symptoms and 499 
comparison children.  Analogous to Rydell’s (2010) study of ADHD and ODD, the 
children did not meet the full diagnostic criteria for ADHD.   
According to Thorell and Rydell (2008), the major finding was that there was no 
main effect for age or group status on the children’s behavior problems.  Despite this, the 
parents of older children, especially those with high levels ADHD symptoms, reported a 
greater negative impact on everyday life and family burden compared to the parents of 
younger children.  Gender did affect both ADHD and behavior.  That is, the boys 
exhibited more severe symptoms of ADHD as well as related behavior problems.  
Implicitly, the gender differences are consistent with the notion that girls with ADHD are 
less likely than boys to display high levels of hyperactivity or impulsivity.  However, 
Thorell and Rydell emphasized that there were considerable differences in externalizing 
behavior and adverse effects of behavior problems between girls with high levels of 
ADHD symptoms and the comparison group girls. 
Thorell and Rydell (2008) found it especially striking that the preschool children 
with high levels of ADHD symptoms had serious behavior problems associated with 
ADHD, thereby implying that behavior problems should not be regarded as simply a 
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long-term consequence of untreated ADHD.  In fact, they are present at a very young age.  
The researchers suggested that conceptualizing preschool ADHD as a “highly complex 
condition with elevated levels of several different types of comorbid deficits” might be 
more conducive to accurate and appropriate diagnosis and treatment (p. 593).  This 
viewpoint is similar to that of Pelham and Fabiano (2001). 
Elkins et al. (2011) included academic performance as one of several 
psychosocial domains in their study of the effects of ADHD and gender.  Raising the 
question of whether there is indeed a “gender paradox” related to ADHD, their main 
issue was whether girls and boys diagnosed with ADHD are affected differently in 
various dimensions of psychosocial functioning.  The participants were drawn from the 
Enrichment Study; an extension of the Minnesota Twin Family Study, designed to 
provide longitudinal data on children at high risk for adolescent substance abuse as a 
result of a childhood disruptive behavior disorder (Keyes et al. 2009).  The participants 
for the Elkins et al. (2011) study were 520 girls and 478 boys, all 11 years old.  The 
children were classified into four groups representing the three ADHD subtypes and a 
comparison group with no ADHD diagnosis.  Clinical interviews disclosed several 
childhood disorders in addition to ADHD, including ODD, CD, depression, and 
separation anxiety.  Measures of academic ability and performance included the 
children’s IQ scores, parents’ reports of academic problems and expectations for their 
child’s academic success, class GPA, and teachers’ appraisals.  Peer relationships were 
assessed via the Popularity Scale from the Piers-Harris Self-Concept Scale (Hur, McGue, 
& Iacono, 1998) to assess the children’s self-concepts and the teachers’ assessments of 
peer relationships. 
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The number and severity of ADHD symptoms were comparable for girls and boys 
(Elkins et al., 2011).  Beyond that commonality, Elkins et al. found a number of 
significant differences in the severity of the problems the children experienced based 
upon gender and ADHD status or subtype.  Compared to their peers without ADHD, the 
girls diagnosed with ADHD experienced more adverse effects socially and academically.  
A predictable finding was that among ADHD subtypes, girls and boys with the combined 
type had the most extensive clinical contact (65.4% and 68.8%, respectively).  However, 
the decisive factor in the observed “gender paradox” was a diagnosis of the ADHD 
inattention subtype.  Specifically, girls with the predominately inattentive subtype had 
much greater difficulties socially and academically than boys with the same diagnosis. 
The girls with predominately inattentive ADHD were especially disadvantaged in 
the academic realm, with significantly lower IQ, GPA, academic motivation, and 
academic expectations and significantly more academic difficulties than boys with the 
same ADHD subtype, as well as compared to girls without ADHD (Elkins et al., 2011).  
Socially, the girls with the inattentive subtype were also less popular and more vulnerable 
to being picked on or bullied than boys in the same ADHD group.  Finding this gender 
distinction somewhat curious, Elkins et al. proposed that academic achievement and 
social status may be more closely related for girls than boys and therefore academic 
underachievement carries more social stigma for girls.  Another possible explanation is 
that girls are expected to be more attuned and responsive to social cues than boys, and 
attention problems interfere with the ability to discern subtle social cues.  It seems 
probable that both explanations play some role in the social rejection of girls with the 
inattention subtype, thus intensifying the magnitude of their social difficulties.  Even 
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more ominous for future adjustment, Elkins et al. noted that being bullied raised the risk 
of internalizing behavior problems. 
The combined ADHD subtype tended to have more negative effects for boys than 
girls (Elkins et al., 2011).  Boys with the combined subtype were less likely to interact 
with prosocial peer role models than girls in the same ADHD group.  Additionally, 
differences between the children with ADHD combined and their peers without ADHD 
tended to be more pronounced for the boys than the girls.  The children diagnosed with 
the ADHD hyperactive-impulsive subtype, of both genders, had the fewest clinical visits 
and were least likely to be on medication, which according to Elkins et al. (2011) could 
explain their lower profile in ADHD research.  Tzang et al. (2008) had expected their 
sample to represent all three ADHD subtypes but none of the children had the H-I 
subtype.  Among the participants from the Enrichment Study, the boys with the H-I 
subtype presented an interesting picture, with high IQs but a significant degree of 
externalizing behavior problems and more deviant peers compared to the boys without 
ADHD (Elkins et al., 2011).  Though they were relatively unimpaired socially as well as 
academically, Elkins et al. noted that their preadolescent profile suggested a high risk for 
future behavior problems and relational aggression.   
In one of the few studies focused exclusively on girls with ADHD, Zalecki and 
Hinshaw (2004) explored variations in aggressive behavior among girls with different 
ADHD subtypes.  The researchers noted that while girls are less likely to exhibit physical 
aggression than boys, they tended to be more predisposed toward relational aggression, 
defined as “harming others by purposefully damaging or manipulating their peer 
relationships, such as by gossiping, spreading rumors, or excluding others from the peer 
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group” (p. 126).  No researchers had previously examined the nature, prevalence, or 
effects of relational aggression in girls with ADHD.  Zalecki and Hinshaw (2004) 
conducted their research in the natural environment of a summer day camp, though the 
participants and staff were all selected for research purposes so that the study would 
synthesize “naturalism and rigor” (p. 127).  The participants were recruited through a 
wide variety of channels, with screening surveys sent out to their parents and teachers.  
The research spanned three 5-week summer programs with 79, 77, and 72 girls, 
respectively.  Most of the girls had never met one another before and the girls diagnosed 
with ADHD and the comparison girls interacted together throughout the summer. 
Observational data was combined with formal assessments, including behavior 
ratings by the camp counselors and peer sociometric nominations (Zalecki & Hinshaw, 
2004).  Teachers and parents provided assessments of relational aggression.  Not 
unexpectedly, the girls with ADHD combined subtype were more overtly aggressive than 
either the girls diagnosed with ADHD-I or the girls without ADHD.  The girls with 
ADHD, including both the inattentive and the combined subtype, were rated as showing 
higher levels of relational aggression than the girls without ADHD by all informant 
groups although there were some distinctions for the two ADHD subgroups.  That is, 
while the ratings of parents and teachers for relational aggression were equivalent for the 
girls with both ADHD subtypes, the counselors and peers perceived much higher levels 
of relational aggression in the girls with the combined subtype.  This discrepancy 
probably reflects differences in the girls’ behaviors in different social settings.  The staff 
members were most likely to witness the girls interacting informally as well as in sports 
and other recreational activities.  Zalecki and Hinshaw (2004) also noted that the 
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association between relational aggression and positive peer nominations was attenuated 
when peer appraisals of relational aggression were excluded from the analyses, thus 
attesting to the importance of soliciting peer perceptions to understand subtleties in social 
aggression. 
In contrast to the findings of Elkins et al. (2011), ADHD-I was less of a social 
liability for the girls than ADHD-C, according to Zalecki and Hinshaw (2004).  Although 
both groups of girls with ADHD were less popular with their peers than the girls without 
ADHD; girls with ADHD-I as well as girls without ADHD who displayed aggressions, 
either relational or overt, still had peers who wanted to be their friends.  That was not true 
for aggressive girls with the combined type, who were significantly more disliked and 
had few peers who wanted to befriend them.  Relational and overt aggression did elicit a 
negative response from peers regardless of whether or not the girls had ADHD diagnoses, 
but the impact was much more intense for the girls with ADHD-C.  Since the study was 
conducted, relational aggression has gained more research attention but perhaps due to 
the overall dearth of attention to girls diagnosed with ADHD, it is rarely examined in the 
context of ADHD. 
Lee and Hinshaw (2006) and Owens, Hinshaw, Lee, and Lahey (2009) both 
explored psychosocial functioning in adolescent girls with an ADHD diagnosis in follow-
ups conducted with girls who had been in the 5-week summer camp research programs.  
Lee and Hinshaw (2006) examined childhood ADHD, conduct problems, academic 
performance, substance abuse, psychological distress, and peer status in a sample of 140 
girls and a comparison group of 88 girls without ADHD who were assessed five years 
after the summer program.  Hyperactivity-impulsivity was significantly linked with 
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conduct problems.  This finding, combined with an earlier study led Lee and Hinshaw 
(2006) to propose that in girls, hyperactivity-impulsivity may reflect the same trait that 
underlies conduct disorder in boys.  Noncompliance was also a predictor of conduct 
problems while overt aggression, covert antisocial behavior, and peer preferences were 
not.  The researchers noted that this finding parallels the role of noncompliance in 
predicting delinquency in boys over 5 years.   
As in the study of Elkins et al. (2011), inattention was associated with poor 
academic performance (Lee & Hinshaw, 2006).  At the same time, neither antisocial 
behavior, hyperactivity-impulsivity, or peer status related to academic performance.  The 
power of inattention to affect the performance of girls with ADHD in the academic 
domain, even after controlling for other factors, led Lee and Hinshaw (2006) to stress the 
significance of inattention in the school realm.  Only the girls with ADHD had histories 
of school suspensions or expulsions during the transition from elementary to secondary 
school.  Additionally, noncompliance and peer status were independently linked with 
behavior problems at school. 
In view of evidence that many youths experiment with substance use in 
adolescence, Lee and Hinshaw (2006) deliberately chose measures that captured 
substance dependence and the range of substances used.  Hyperactivity-impulsivity 
proved to be the main predictor of substance dependence while noncompliance was 
significantly linked with using a variety of different substances.  Hyperactivity-
impulsivity was also the ADHD symptom most closely linked with internalizing 
symptoms.  However, the most notable finding, according to the researchers, was the 
association of covert antisocial behavior with self-reported depression and of 
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noncompliance with internalizing symptoms.  Lee and Hinshaw (2006) noted that 
internalizing and externalizing symptoms are often found in conjunction in girls, and girls 
are more susceptible to depression in adolescence.  The range of behaviors included in 
the analyses highlighted the different ways in which symptoms of ADHD can manifest in 
girls.  To Lee and Hinshaw (2006), the detrimental impact of externalizing behavior on 
the transition to adolescence underscores the importance of early intervention for ADHD 
and associated behavior problems. 
Owens et al. (2009) conducted their research with the same sample of 140 girls 
with ADHD and 88 comparison girls included in the study of Lee and Hinshaw (2006), 
also analyzing the trajectory of ADHD on psychosocial functioning and symptoms 
manifestation in a number of psychosocial domains.  Among the girls diagnosed with 
childhood ADHD, close to 20% had virtually no ADHD symptoms in adolescence.  
However, less than half the girls with ADHD scored below the researchers’ criterion for 
internalizing problems (49.2%) or externalizing problems (42.1%), while the 
overwhelming majority of the comparison girls were below the same threshold (85.2% 
for internalizing problems and 91.3% for externalizing problems).  More than twice as 
many comparison girls, as girls with ADHD, had sufficient social skills (82.7% versus 
40.5%).  The girls without ADHD also fared better on teacher ratings of social status and 
achievement in mathematics and reading. 
In total, Owens et al. (2009) explored the participants’ adjustments in adolescence 
across six dimensions: ADHD symptoms, externalizing problems, internalizing problems, 
social skills, academic performance, and peer acceptance.  Between roughly 20% and 
65% of the girls with childhood diagnoses of ADHD were positively adjusted with each 
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of the six dimensions, but in each dimension the proportion of girls with ADHD was 
significantly lower than the proportion of girls without ADHD.  In addition, only 16.5% 
of the girls with ADHD showed positive adjustment in at least five dimensions compared 
to 86.4% of the comparison group.  Owens et al. noted that even when psychiatric 
symptoms were excluded from the analyses, differences in the positive adjustment of the 
ADHD group and the comparison group remained. 
Within the ADHD diagnostic categories, Owens et al. (2009) found that the girls 
with the inattention subtype fared somewhat less well in positive adjustments than those 
with the combined type.  Although this finding contrasts with the popular assumption that 
the combined type is “worse” than the inattentive type, this pattern is consistent with the 
findings of Elkins et al. (2011) for girls diagnosed with ADHD.  Owens et al. noted that 
there is additional evidence that the inattentive type is linked with negative psychosocial 
functioning and the symptoms of inattention are less likely to disappear over time.  One 
area in which Owens et al. called for further research was in identifying the factors 
associated with positive adjustment which may allow for the early detection of children 
who are least likely to “grow out of” their symptoms as they mature. They also called for 
the development of appropriate interventions.          
Medication Treatment and Comorbidity 
Ter-Stepanian et al. (2010) investigated the influence of comorbid disorders on 
the course of response to medication with methylphenidate in children diagnosed with 
ADHD.  The research, conducted at the Douglas Mental Health University Institute in 
Montreal, took the form of a randomized, double blind, placebo controlled 2 week 
crossover trial of stimulant medication involving 267 children with ADHD ranging in age 
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from 6 to 12 years.  Parents’ and teachers’ ratings were used in conjunction with clinical 
assessments.  More than 80% of the children were diagnosed with one or more comorbid 
psychiatric disorders.  Close to half (47.2%) of the children met diagnostic criteria for 
anxiety, 40.8% for ODD, 27.7% for CD, and 7.9% for depressive disorders.  More than 
one-third of the children had comorbid ADHD and ODD or CD and an anxiety or 
depressive disorder.  Boys predominated (77.9%) and a sizable proportion of the 
participants came from economically disadvantaged families. 
According to Ter-Stepanian et al. (2010), the degree of comorbidity in their 
sample highlighted the complex clinical symptomology of children with ADHD.  More 
than one-third of the children were referred by the Severe Disruptive Disorders Program, 
which included a day hospital.  The presence of multiple comorbidities did not weaken 
the effect of the stimulant medication, but there were differences in medication responses 
contingent on the specific disorder.  The children diagnosed with ADHD and ODD or CD 
tended to respond favorably to medication according to parent and teacher reports.  
Stimulant medication directly and indirectly affected the disruptive behavior the children 
displayed.  At the same time, changes in the behavior of children with these disorders 
was easily detectable to observers and those with whom the children interact, which 
could account for some degree of the high response rate. 
In contrast to the positive impact of medication on the children with comorbid 
ODD and CD, the presence of an anxiety disorder decreased the effectiveness of 
methylphenidate. Ter-Stepanian et al. (2010) suggested that cognitive behavior therapy 
(CBT) combined with medication would be an effective treatment for children with 
comorbid ADHD and anxiety.  Van der Oord, Prins, Oosterlann, and Emmelkamp (2007) 
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also suggested that children with comorbid ADHD and anxiety might benefit from CBT 
intervention.  There own study found no support for the assumption that children with 
ADHD taking an optimum dosage of stimulant medication would gain additional benefits 
from behavioral interventions.  However, they emphasized treatment must be tailored to 
each child’s individual needs.  Children from low-income families tended to respond well 
to the medication and indeed, low-income children with ADHD tended to use stimulant 
medications at higher than average rates (Ter-Stepanian et al., 2010).  Genetic and 
environmental factors may play a role in the treatment response. 
Faber et al. (2010) explored the treatment patterns of children diagnosed with 
ADHD in the Netherlands with emphasis on the use of stimulant medication and the 
presence of comorbid disorders.  Children under 16 taking stimulant medication for 
ADHD were identified from the records of pharmacies and the researchers sent 
questionnaires to the prescribing physicians.  The survey produced 510 completed 
questionnaires, with 31% of the children having one or more comorbid psychiatric 
conditions.  The most prevalent comorbid condition was pervasive developmental 
disorder (10.4%), which is unusual in U.S. research on ADHD.  In fact, the overall rate of 
comorbidity was low.  Additional comorbid diagnoses included ODD or CD (9.8%) and 
LD (5.5%), with small numbers of children diagnosed with mental retardation, tic 
disorder, and anxiety disorder. 
According to the physician reports, the children diagnosed with ADHD and 
comorbid conditions were more likely than those with ADHD alone to be involved in 
psychosocial interventions in conjunction with medication.  They were also more likely 
to be taking psychotropic medications as well as stimulant medications, which Faber et 
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al. (2010) attributed to the number of children with PDD.  They also suggested that the 
number of children participating in psychosocial interventions might be underestimated 
because the physicians might have been unaware of them.  Combined medication and 
psychosocial treatment was generally recommended for children with ADHD and in 
particular, for children with ADHD and comorbid disorders. 
Oppositional defiant disorder.  Research has shown that children with comorbid 
ADHD and ODD respond favorably to the combination of counseling and psychotropic 
medication (Biederman et al., 2007).  The cornerstone of medication treatment for 
ADHD and ODD generally involves treating the symptoms of poor impulse control, 
anger and irritability with stimulate medications such as methylephenidate. Additional 
classes of medication have also been shown to be effective in treating comorbid ADHD 
and ODD including atypical agents (aripiprazole) antidepressants (fluoxetine) and beta 
blockers (atomoxetine).  Of the previously mentioned classes of medication, there is far 
less research on the use of atomoxetine for treating children with ADHD than the 
extensive body of research on methylphenidate.  In addition, there is limited research on 
atomoxetine for treating comorbid ADHD and ODD (Biederman et al., 2007).  
Biederman et al. presented a meta-analysis of the results of three randomized, double 
blind, placebo controlled trials of children and youth between the ages of 6 and 16.  The 
participants received either a placebo or atomoxetine every day for 6 to 8 weeks.  Out of 
512 participants, 158 were diagnosed with comorbid ADHD and ODD.  Compared to the 
placebo, atomoxetine resulted in a significant decrease in ADHD symptoms regardless of 
the presence or absence of ODD.  Additionally, the medication treatment produced 
significant improvements on most dimensions of psychosocial functioning in the children 
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with ADHD only and comorbid ADHD and ODD.  In fact, the decrease in ODD 
symptoms was heavily dependent upon the intensity of the ADHD response.  The overall 
findings confirmed that the presence of ODD did not interfere with the children’s 
response to atomoxetine.    
 Callous and unemotional traits.  Waschbush et al. (2007) investigated the 
effects of behavior modification with and without methylphenidate medication in 
children with ADHD and conduct problems, including the prospective role of callous and 
unemotional traits on the children’s academic and social competence.  There is some 
evidence that callous and unemotional traits, such as lack of empathy and remorse, 
heighten the risk for future antisocial behavior in children with conduct problems.  Early 
onset conduct disorders often occur in conjunction with ADHD and the behavior of 
children with conduct problems can be considerably different depending upon the 
presence of callous and unemotional traits.  Prior to this study, there was considerable 
disagreement regarding whether this affects a child’s response to behavioral 
interventions, and no previous research had examined the effects of stimulant medication 
on children with ADHD and conduct problems (CP) with and without callous and 
unemotional (CU) traits. 
The participants in the study by Waschbush et al. (2007) were 29 boys and 8 girls 
with an age range from 7.24 to 12.53 years who had attended the Summer Treatment 
Program (STP).   All the participants had diagnoses of ADHD-C (combined type) in 
conjunction with either ODD (43.2%) or CD (56.8%).  Callous and unemotional (CU) 
traits were assessed on the basis of parent and teacher ratings using the Antisocial Process 
Screening Device (Frick & Hare, 2001).  Nineteen of the children scored below the cut-
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off point and 18 scored above the cut-off and were designated the ADHD/CP-CU 
(conduct problems and callous and unemotional) group.  All of the children participated 
in the STP activities which included behavioral feedback.  The medication regimen 
utilized an individualized within-subject, placebo controlled format.  After an initial 2-
week baseline period, each child was involved in a 6-week medication assessment to test 
the effects of the placebo.  Medication was assigned randomly and due to absences, there 
were individual differences in the number of days the children received low dose or high 
dose medications or a placebo, but there were no differences in the average medication 
days or dosage according to group (ADHD/CP-only or ADHD/CP/CU). 
The findings demonstrated that when the children received behavior therapy 
without medication, those who had callous and emotional traits in additional to ADHD 
and conduct problems displayed more antisocial behavior than their peers with ADHD 
and conduct problems alone (Waschbusch et al., 2007).  The group distinctions that 
emerged centered mainly on conduct problems, rule following, and noncompliance rather 
than on behaviors such as classroom seatwork, helping and sharing or on ADHD 
symptoms such as disruptive behavior.  While acknowledging that the reason for this 
pattern is uncertain, Waschbusch et al. proposed that results may have reflected 
differences in the baseline prevalence of antisocial behaviors.  In other words, children 
with callous and emotional traits initially had markedly higher levels of antisocial 
behavior, which behavior therapy alone was inadequate to change.  Another prospective 
explanation was that children with callous and emotional traits reacted differently to 
behavioral reinforcements. 
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Notably, the group differences decreased dramatically when the children took 
stimulant medication in addition to participating in behavior therapy (Waschbusch et al., 
2007).  In fact, the responses of the children to the stimulant medication surpassed the 
expectations of the researchers, who expected their medication responses to be less 
pronounced than the children with ADHD and conduct problems only.  There is some 
controversy on the question of whether the reduction of impulsivity allows children with 
antisocial tendencies to engage in more planned antisocial behavior, but that did not turn 
out to be the case.  At the same time, Waschbusch et al. acknowledged that the 
assessment tool they used was not sensitive enough to discern whether the antisocial 
behavior was planned or unplanned.  There was some evidence that stimulant medication 
may have decreased some manifestations of antisocial behavior but increased others.  
Waschbusch et. al also noted that while there were few significant group differences, 
individual differences between participants suggested that overall, treatment was less 
likely to normalize the behavior of children who displayed callous and emotional traits in 
addition to ADHD and conduct problems.           
Psychosocial ADHD Treatments 
Pelham and Fabiano (2008) built on a research review conducted by Pelham, 
Wheeler, and Chronis (1998) examining evidence-based psychosocial interventions for 
children with emotional and behavioral disorders (EBD).  The original research review 
produced several conclusions.  First, behavioral parent training marginally met criteria 
for well-established treatment, but it did meet criteria for a probably efficacious 
treatment.  Second, classroom behavior contingency management had an extensive 
evidence base.  Third, there was additional support for classroom interventions found in 
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studies conducted before DSM-III became widely used, documenting the effectiveness of 
behavior modification for children with inattention or disruptive behaviors although not 
formally diagnosed with ADHD.  Fourth, there was insufficient evidence in support of 
social skills training or other peer interventions.  Fifth and finally, there was no empirical 
support for cognitive interventions for children with ADHD. 
In view of the upsurge in research on psychosocial treatments for ADHD since 
1998, Pelham and Fabiano (2008) examined studies that had been conducted since the 
original research review.  The empirical evidence bolstered support for the effectiveness 
of behavioral parent training, and behavior contingency management, and also 
documented the effectiveness of intensive, peer oriented behavioral programs conducted 
in recreational environment such as summer programs.  The overarching conclusion was 
that ADHD is a chronic disorder and therefore it is misguided to believe that a “brief, 
time-limited [original emphasis] treatment regimen” regardless of its nature would be 
“sufficient and effective” for treating children with ADHD (p. 209).  Pelham and Fabiano 
(2008) emphasized that most children with ADHD will require prolonged “chronic, 
intensive, pervasive, palatable treatment that promotes engagement and adherence” (p. 
210). 
Reeves and Anthony (2009) outlined several benefits of employing multimodal 
treatment rather than medication alone for children and adolescents with mental health 
disorders.  First, psychosocial interventions offer an opportunity for parents to be actively 
involved in their child’s treatment and to learn parenting skills that can have a positive 
impact on other siblings, as well as the target child.  Second, medications may address 
disease-specific symptoms, but not the full scope of “symptoms-related” problems such 
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as impaired family or peer relationships, ability to cope with stress, or entrenched 
aggressive behaviors.  Essentially, this corresponds to Pelham and Fabiano’s (2001) call 
to treat impairments rather than symptoms.  Both sources agree that psychosocial 
treatments can have a powerful impact on child and family functioning that may decrease 
the need for medication.  Third, the time spent engaged in psychosocial interventions can 
mean more time for support and time for the clinician to assess a child’s safety in areas 
such as suicidal feelings or child abuse (Reeves & Anthony, 2008).  Multimodal therapy 
also allows clinicians more time to spend with parents discussing medication issues as 
well as the child’s overall treatment.  
Multimodal Treatment Study of ADHD 
The Multimodal Treatment Study of ADHD (MTA) was a randomized clinical 
trial sponsored by the National Institute of Mental Health (NIMH) and conducted at 6 
sites (MTA Cooperative Group, 2004a).  A sample of 597 children diagnosed with 
ADHD combined type between the ages of 7 and 10 were randomly assigned to 1 of 4 
modes of therapy: medication management, behavior modification, combined medication 
management and behavior modification, and routine care community treatment.  At the 
end of the initial 14-month treatment phase, all four groups of children displayed 
substantial improvements, though some differences were observed.  Medication 
management and combined therapy were both more successful in treating ADHD 
symptoms than behavior management alone or routine community care.  On subjective 
assessments, the combined treatment was superior to all three of the other treatments 
based on oppositional and aggressive and internalizing symptoms reported by parents’ 
and teachers’ assessments of social skills, parent child relationships, and reading 
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performance.  While two-thirds of the children receiving community treatment were 
taking medication, the intensive MTA medication regimen proved more effective. 
The researchers attempted to identify characteristics that would predict the 
children’s responses.  However, rather than predictors they found moderators in 
treatment response (Owens et al., 2003).  Specifically, medication management and 
combined treatment were linked with lower rates of “excellent response,” defined as the 
reduction of ADHD and ODD symptoms to a level at or near the normal range in children 
who began the study with extremely severe ADHD symptoms or had depressive 
symptoms according to parents’ reports.  Excellent response rates were particularly low 
when the child also had an IQ below 99.  None of the characteristics examined moderated 
the effects of behavior therapy alone or community care treatment.  
A critical point for the MTA was whether the treatments would have enduring 
effects.  The first follow-up was conducted at 24 months, with data from 540 children 
(MTA Cooperative Group, 2004a).  The follow-up affirmed the superiority of the MTA 
medication management and the combined medication management and behavior 
modification over behavior modification alone and routine community care.  However, 
the effect size was only half as large after 24 months than at 14 months for both ADHD 
and ODD.  Consistent but non-significant effects were observed for the superiority of the 
combined treatment over intensive medication management alone on measures of ODD 
symptoms, social skills, and parental discipline, along with overall normal adjustment.  
This pattern reflected similar findings at 14 months. 
According to the researchers, the finding suggested that the high dosage of 
medication used by the medication management and combined MTA groups provided an 
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early advantage that lingered even if the children stopped taking the medication after 14 
months (MTA Cooperative Group, 2004a).  Nevertheless, the effects of intensive 
medication management dissipated over time.  Though non-significant in the quantitative 
analysis, the behavior modification techniques appeared to have given a social advantage 
to the children in the combined group that extended beyond the effects of ADHD 
symptom reduction. 
The MTA researchers also examined the effects of the intensive medication 
regimen on the growth of the children, which also entailed a more detailed analysis of the 
dosage and maintenance of the stimulant medication (MTA Cooperative Group, 2004b).  
The analysis suggested that the decline in effectiveness during the follow-up stage might 
have been due to a reduction in medication as opposed to a decrease in effectiveness of 
the stimulant medication over time.  According to the researchers, this explanation is 
consistent with the prevalent viewpoint that stimulant medication effectively treats 
symptoms of ADHD, but it does not have enduring effects once the medication is 
stopped.  On the other hand, while behavior modification had a less powerful impact than 
medication, it can produce lasting benefits if the behavior is generalized and reinforced. 
The researchers were somewhat surprised by the number of children in the 
medication management and combined treatment groups who stopped taking stimulant 
medication after the study and the number of children in the behavior modification group 
who did not take medication (MTA Cooperative Group, 2004b).  However, while 
clinicians may find this counterintuitive, the parents’ reports of satisfaction with 
treatment revealed that the parents in the behavior management group were more 
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satisfied with treatment than those in the medication management group and reported 
equivalent improvements despite the objective differences in symptom reduction. 
There is no clear understanding of how treatment preferences and availability 
influence the treatment planning of families of children diagnosed with ADHD 
(Brinkman & Epstein, 2011).  Brinkman and Epstein conducted a research review on the 
topic, which disclosed a number of factors that influenced the initial decision in choosing 
treatment after the child’s ADHD diagnosis.  The family’s beliefs about the nature of the 
child’s disorder play a major role in the choice of treatment, along with the information—
or misinformation—they acquired from various sources.  Over time, their treatment 
preferences were shaped by their own experiences with different therapeutic modalities, 
and whether or not treatment plans were continually reassessed and revised.  As 
described by Brinkman and Epstein, the process entailed an ongoing cost-benefit analysis 
in which the family works with their health care team to create a treatment plan that 
maximizes the benefits to the child and minimizes detrimental effects and costs. 
Undesirable side effects are often the cause for individuals to stop taking 
medication even when it helps the condition for which it is prescribed.  The MTA 
researchers acknowledged that their evaluation of treatment effectiveness did not include 
ratings of medication side effects, tolerance, adaptive functioning, or quality of life, 
which are important elements of subjective satisfaction with treatment (MTA 
Cooperative Group, 2004b).  The one medication side effect that was examined as part of 
the MTA was possible growth suppression from taking stimulant medication.  There was 
some evidence of this phenomenon in that the children who continually took medication 
grew at a somewhat slower rate than those taking no medication.  At the same time, there 
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could be other factors affecting the children’s growth.  The researchers emphasized that 
there is no way to predict how medication would affect the eventual size of preadolescent 
children.  In addition, they pointed out that stimulant medication did not seem to affect 
the adult height of the now adult participants in studies of ADHD medication conducted 
in the 1970s. 
Karpenko et al. (2009) investigated the relationship between clinically significant 
changes in the symptoms of ADHD and ODD and reliable improvement in psychosocial 
functioning across multiple domains among MTA participants.  The analysis was based 
on 417 children using data from baseline and 14-month assessments.  The results 
demonstrated that the children who experienced clinical changes in ADHD and ODD 
symptoms had a significantly higher probability, than those with no clinical changes, to 
enjoy reliable improvements on 6 out of 9 psychosocial indices. 
An intriguing finding, however, was that 14% to 52% of the children who did not 
display clinically significant change also showed reliable psychosocial improvement, 
depending upon the particular domain (Karenko et al., 2009).  The most marked 
improvements were in the areas of parent-rated social competence (52%), teacher-rated 
social competence (49%), and homework (45%).  In addition, 35% showed 
improvements in the pervasiveness and severity of their attention difficulties at home.  
Karpenko et al. acknowledged that these positive changes might be more meaningful for 
parents and teachers than changes in the clinical symptoms of ADHD and ODD.  There is 
often a discrepancy in the perceptions of parents, teachers, and clinicians.  
Comprehensive instruments that are able to capture the full spectrum of behaviors 
associated with ADHD would provide a more multifaceted portrait of change that occurs 
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with treatment.  De Los Reyes and Kazdin (2006) created a Range of Possible Changes 
Model encompassing multiple outcome measures, multiple informants, and multiple 
analytic strategies.  Karpenko et al. recommended future research using the model.      
Molina et al. (2009) presented recent findings from the MTA when the 
participants were assessed 6 years and 8 years after the initial study.  For the most part, 
the analyses included the same variables that were used in the earlier MTA reports and 
extended them into the domains of adolescent functioning.  The measures included 
parents’ and teachers’ assessments of ADHD and ODD symptoms, aggression and 
conduct; parent and youth reports of delinquent behavior, contact with the juvenile justice 
system; parents’ assessments of functional impairments; self-reported depression and 
anxiety symptoms; various measures of school functioning and academic performance; 
social competence; psychiatric hospitalizations; and driving accidents or citations for 
those old enough. 
The participants’ randomized treatment groups, when they entered the study, had 
no major impact on their ADHD and psychosocial trajectories, but the course of ADHD 
symptoms in childhood emerged as a powerful predictor of adolescent outcomes after 6 
and 8 years (Molina et al., 2009).  Overall, while there was general improvement from 
the time of the study, the participants with ADHD still fared less well over time than the 
classmate comparison group that entered the study at the time of the 24-month 
assessment.  The psychosocial and symptom profiles of the participants when they began 
the study were the key predictors of functioning in mid or late adolescence.  These factors 
included the degree of ADHD symptoms severity, intellect, conduct problems, social 
competence, and the magnitude of the initial responses to ADHD treatment rather than 
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the type of treatment per se.  The most favorable outcomes were found for participants 
who entered the study with lower symptoms severity, fewer conduct problems or learning 
problems, higher IQs and social skills, and families that were more stable and more 
affluent.  These participants also had the most marked and enduring declines in ADHD 
symptoms at 36 months. 
Some of the participants continued to take medication 6 or 8 years after they 
entered the MTA, but the only advantage medication seemed to offer was for 
mathematics achievement (Molina et al., 2009).  While 30% of the participants no longer 
met DSM-IV criteria for ADHD, Molina et al. were skeptical of whether the criteria may 
be too stringent to capture manifestations of ADHD in adolescence and adulthood.  Their 
overarching conclusion was that there is an urgent need for devising treatments that are 
effective, accessible and with lasting benefits, for teenagers diagnosed with ADHD and 
their families.  They also noted that adherence to ADHD medication tends to decline 
drastically with the onset of adolescence.  One recommendation is to encourage youth to 
participate periodically in psychosocial interventions, a strategy that has some empirical 
evidence.  For this practice to become more prevalent there must be an accompanying 
effort to develop developmentally appropriate, engaging interventions for adolescents.  
MTA Study: Comparing Subgroups  
Another study which has emerged from the large, controlled clinical MTA study 
addressed whether ADHD with co-existing comorbidities should constitute separate 
clinical entities. Drawing upon cross-sectional and longitudinal information, Jensen et al. 
(2001a) studied 579 children who were assigned randomly to one of four groups, based 
on the presence of comorbid conditions: ADHD alone; ADHD with an anxiety disorder; 
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ADHD with either oppositional defiant disorder or conduct disorder; and ADHD with 
both an anxiety disorder and either oppositional defiant disorder or conduct disorder. This 
division of the participants revealed that the relative effectiveness of the different 
treatments depended on the condition of the children. Participants diagnosed with ADHD 
and anxiety responded equally well to all three experimental conditions – medication 
alone, behavioral alone, or the combination. The ADHD-only and ADHD plus conduct 
problems groups responded only to treatments including medication. The group with all 
three conditions appeared to derive substantially greater benefits from combination 
interventions compared with all other treatments (Jensen et al., 2001a).  
The Jensen et al. (2001a) findings are very important, partly because of the 
implications for understanding and treating ADHD in children and partly because they 
illustrate the importance of conducting analyses in which the subjects are disaggregated 
and not viewed as if they were a homogeneous entity. This type of analysis allows 
researchers to determine how to best match treatments with characteristics of individuals. 
The Jensen et al. (2001a) study gave us a better understanding for making a case to 
consider differing ADHD classifications across ADHD subtypes.  
Alternative Intervention Programs 
Few research studies have investigated the efficacy of intensive intervention 
programs for children suffering with ADHD and the presence of comorbid conditions.   
Barkley et al. (2000) studied annual screenings of 158 preschool children with ADHD 
symptoms including aggressiveness, hyperactivity, impulsivity and inattention behaviors. 
Children were randomly assigned to one of four treatment groups for the entire school 
year: 1) no treatment, 2) parent training only, 3) full-day treatment classroom only, or 4) 
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the combination of parent training with classroom treatment. Their findings suggested 
that “when parent training is offered at school registration to parents of disruptive 
children identified through a brief school registration screening, it may not be a useful 
approach to treating children in home and the community…most treatment effects were 
specific to the school environment and did not affect achievement skills” (p. 319).   
August, Realmuto, Hektner, and Bloomquist (2004) studied elementary school 
children with early onset aggressive behavior. The program that they studied was called 
The Early Risers Program. This program featured 4 CORE components: a) an annual 6 
week summer school program b) a teacher consultation and student mentoring program, 
c) child social skills groups, and d) parent education and skills training groups. August et 
al. (2004) found children participating in the program showed significant improvement in 
academic achievement and school behaviors. Results showed that both girls and boys had 
similar treatment responses. 
Goossensen, Glind, Carpentier, Wijsen, Duin and Kooij (2006) studied an 
intervention program for inpatients diagnoses with both ADHD and substance use 
disorders (SUD).  Although the sample consisted of adults, the research investigated an 
intervention program for screening, diagnosis and treatment of ADHD in patients with 
SUD.  Just as there is a lack of intervention programs for children with ADHD and 
comorbidity, Goossensen et al. (2006) reported the comorbidity of attention deficit 
hyperactivity disorder is frequently not well recognized in substance abuse treatment and 
that ADHD comorbidity treatment is lacking.  Results from their study found the 
intervention program: “1) feasible to implement, 2) more than 20% of new patients 
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screened positive, and 3) 60% of those patients met criteria for ADHD” (p.259).  Further 
research was encouraged to address substance abuse treatment with comorbid ADHD. 
Summer Treatment Program  
One treatment program, the Summer Treatment Program, which provides 
treatment for children diagnosed with ADHD has not yet generated much research that 
considers the treatment of ADHD with comorbid disorders. The intensive Summer 
Treatment Program uses a variety of evidenced-based strategies across academic and 
behavioral settings (Coles et al., 2005).  The program is based on a token economy in 
which the children earn points for appropriate behaviors and lose points if they behave 
inappropriately.  Although the format is not unusual for a behavior modification program, 
the STP strands out for its fusion of recreational and academic activities with therapeutic 
treatment.  Serious behavior transgressions (such as intentional aggression, intentional 
destruction of property, and repeated noncompliance) are met with a time out.  
Conversely, the staff members continually reinforce positive social behavior with praise.  
Classroom instruction includes seatwork, peer tutoring, technology instruction, and art.    
The children are given daily report cards on which the clinical staff members establish 
each child’s individual target behaviors and goals for recreational and academic 
activities.  The parents attend weekly training sessions where they learn how to reinforce 
and reward prosocial behavior based on the daily report card performance.  In addition, 
the counselors hold social skills training sessions each morning and reinforce the exercise 
of appropriate social skills throughout the day and weekly parent training are held.  The 
program is further outlined in detail in Chapter Three. 
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When the standardized behavioral therapy is inadequate for inducing positive 
behavioral change, the child is given an individually tailored behavior program targeting 
his or her specific problem areas (Coles et al., 2005).  For evaluation purposes, the 
behavior modification protocols were suspended for two weeks.  During that time, the 
atmosphere reverted to a more typical summer camp, and the children went on trips or 
used other privileges they earned.  Negative behavior was halted only when it became 
disruptive or threatening to others. 
Coles et al. (2005) focused on four children, 3 boys and 1 girl, each one with 
different behavior patterns.  All four children enjoyed substantial improvements in 
behavior, though there were some differences according to the settings where the 
behavior change was most evident. The study design allowed the researchers to 
distinguish individual program effects and evaluate the overall program success at the 
same time.  For example, one boy had marked improvements in recreational activities but 
fewer improvements in the academic setting while for another boy the effects were 
reversed.  It is noteworthy that the boy who fared well in the recreational setting had a 
relatively low IQ which made it harder for him to transfer behavior from a formal to an 
informal environment. 
 Unlike the inconsistent patterns exhibited by the two boys, the girl showed 
decisive benefits from the program across different settings.  She had comorbid ODD and 
an above average IQ (the highest of the four children).  Three of the four children were 
diagnosed with ODD and one boy was diagnosed with CD.  Coles et al. (2005) stressed 
that the children had differences in comorbid disorders, internalizing versus externalizing 
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behaviors, intellect, medication treatment, and other characteristics.  Overall, the four 
children made meaningful and substantial gains in behaviors. 
Pelham et al. (2002) examined the effects of stimulant medication 
(methylphenidate) and expectancy on the behavior, academic performance, and 
attributions of 136 boys attending the STP over four summers.  Expectancy conditions 
were established by manipulating the children’s beliefs of whether they were taking a 
stimulant pill or placebo.  The design was a within-subject, balanced placebo with daily 
crossovers among four conditions (accurately told placebo, placebo received real 
medication, real medication but told placebo, accurately told real medication). 
The results of the experiment showed that taking a low dose of stimulant 
medication produced improvements in the boys’ behaviors and substantially increased the 
probability that they would meet their behavioral goals (Pelham et al., 2002).  Expectancy 
about medication had an influence on their predictions for success that day but it did not 
affect their behavior.  The boys made stronger internal than external attributions for 
success but were adamant in denying internal causes for failure.  Taking the stimulant 
medication improved the boys’ behaviors on nearly all dimensions in both recreational 
and academic environments as well as helping them reach their behavioral goals. 
A second experiment examined whether the results Pelham et al. (2002) observed 
in the STP would be generalized to the natural classroom environment.  The study took 
place with 110 of the 136 boys during the school year in their regular classrooms.  Apart 
from the medication protocol and the daily report card used in the STP, there were no 
changes made to the natural setting.  The medication effects and attributions paralleled 
those observed in the structured STP setting.  There was clear and compelling evidence 
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of the positive impact of stimulant medication and no evidence that the children felt that 
their success was dependent on medication rather than their control of their own 
behavior.  According to Pelham et al. it was important that the children did not feel 
unduly dependent on mediation but at the same time, if they felt medication did not affect 
they behavior, they may decide to stop taking it, which is often the case among 
adolescents (Molina et al., 2009).  Overall, Pelham et al. (2002) viewed the effects of 
medication on behavior as highly positive.  The children’s successes imbued them with 
confidence, which served as further motivation for prosocial behavior. 
Fabiano et al. (2007) explored the effects of varying intensities of 
methylphenidate and behavior modification with 44 boys and 4 girls attending the STP.  
For each type of treatment the intensity was high, low, or no treatment.  Behavior 
modification treatment was varied in blocks of 3 weeks, with the order randomly 
assigned by group.  The medication varied on a daily basis and was randomly assigned 
for each child.  The study focused on classroom behaviors, using the standard STP 
behavioral protocols.  The results affirmed the effectiveness of medication and behavior 
modification independently and combined.  Fabiano et al. also noted that a low dose of 
medication (0.15 mg/kg) was sufficient to produce a dramatic increase in academic 
productivity and increasing the dose resulted in no more than modest increases.  The 
standard dose of methylphenidate is usually twice as high. 
Low intensity behavior modification was as effective as the other interventions 
with the exception of the highest medication dose or a combination of high intensity 
behavior modification and medication (Fabiano et al., 2007).  According to Fabiano et al., 
the key implication of their findings was that children taking high doses of stimulant 
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medication may be able to decrease the dosage, or possibly the need for medication, if the 
teacher implements behavior modification techniques in the classroom.  They suggested 
that parents work with teachers to develop a plan and that doctors and school mental 
health professionals involved with medication trials should routinely survey the 
effectiveness and extent of behavior modification practices, which can be successfully 
implemented in most classrooms.     
Pariseau et al. (2010) examined whether having additional time would improve 
the performance of children with ADHD on academic assignments in a group of 33 
children attending the 2007 STP.  According to the researchers, the provision of extra 
time may actually be counterproductive for children with ADHD, who have difficulty 
with sustained attention.  The study took place during afternoon seatwork when the 
children were working on three assignments: math fluency workbooks, a reading 
exercise, and a writing exercise.  The children had either 30 minutes or 45 minutes to 
finish their assignments.  The results, which were based on accuracy and rule following 
during the assignment, confirmed the theory that extended time is not helpful for children 
with ADHD.  Notably, the children’s work was more accurate when they had to complete 
it within the shorter time period.  Pariseau et al. added that the behavior modification 
strategies used in the STP might have allowed the children to complete more accurate 
work during the standard time period.  Given that children with ADHD have to 
participate in high-stakes assessments and an important treatment goal is to improve 
academic performance, children with ADHD need strategies that are proven with that 
specific population. 
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Lopez-Williams et al. (2005) examined the role of athletic performance and social 
behavior in the social acceptance of 63 children with ADHD enrolled in the STP.  
Recreational activities were an important feature of the summer program and included 
skills training in soccer, basketball, baseball, and swimming.  For the purpose of the 
study, the researchers focused on two types of athleticism: general athletic performance 
and performance in a specific sport.  Standardized performance measures were developed 
by several researchers working together.  Social behavior was assessed and recorded 
continually throughout the program.  Peer nominations and sociometric ratings were used 
to assess peer acceptance. 
Both athletic performance and social behavior proved to be significant factors in 
the social acceptance of children with ADHD.  Lopez-Williams et al. (2005) noted that in 
general, athleticism is an important dimension of children’s social worlds; therefore it is 
not surprising that it should affect the social behavior of children with ADHD.  The more 
athletic the children according to the measures used for the study, the more popular the 
child was likely to be with the group, the more likely to be nominated as a best friend, 
and the less likely to face rejection.  Negative social behavior was also a powerful 
predictor of acceptance but in the opposite direction; in short, negative behavior was 
linked with social rejection and the more negative behavior the more likely the child was 
to be rejected by peers.  On the other hand, positive behavior made others want to 
befriend the child.  One aspect of the association between athletic performance and social 
acceptance that Lopez-Williams et al. did not address was the impact that ADHD 
symptoms had on athletic performance.  While athletic children may generally be 
popular, children who excel in structured athletic activities would be unlikely to exhibit 
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disruptive behaviors that interfere with the game or meet.  That is, an additional reason 
why children who perform well in sports may be popular with peers is that they are able 
to control their behaviors.  This proposed association between social behavior and 
athletic performance may have been captured by the behavioral observations at the STP, 
though it was not explicit. The STP program is further outlined in detail in Chapter 3. 
Conclusion 
ADHD has been identified as one of the most common reasons for referral to 
professionals who care for children’s mental health, health, and educational needs 
(Anastopoulos & Farley, 2003; Pelham & Waschbusch, 2004), and it is often 
accompanied by comorbid disorders, notably ODD, CD, LD, anxiety, and depression.  
Pharmacological treatment with stimulant medication has emerged as the first line 
treatment for children with ADHD.  However, medication does not produce lasting 
effects (Molina et al., 2009).  Furthermore, medication alone may only address the 
specific symptoms of ADHD and still leave children with psychosocial problems that 
disadvantage them socially and academically.  In addition, the customary high doses may 
have unpleasant side effects.  There is a growing body of empirical evidence supporting 
the effectiveness of psychosocial interventions for children with ADHD (Pelham & 
Fabiano, 2001, 2008).  Through the involvement of parents, teachers, other important 
adults, and peers, children diagnosed with ADHD learn to master prosocial skills, 
providing they are continually reinforced.  Behavioral treatment plans can be 
individualized to each child’s needs, which is important given the numerous individual 
variations.  The critical issue is that the target behavior must be continually reinforced in 
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the natural environment.  The most effective therapy for children diagnosed with ADHD 
may be multimodal, intensive, sustained, and individualized.       
In conclusion, there is substantial existent literature examining both treatment and 
intervention programs for those diagnosed with ADHD and learning disabilities, 
internalizing and externalizing disorders and substance abuse.  However, there is an 
absence of research that examines the effectiveness of comprehensive intervention 
programs for the treatment of ADHD with other comorbid conditions.  Specifically, a 
review of the literature found no studies or programs suggesting children from differing 
age groups, gender or comorbid diagnoses benefit from an intensive comprehensive 
intervention program such as the Summer Treatment Program. Therefore, this 
dissertation research is intended to gain more knowledge about children diagnosed with 
ADHD and a comorbid diagnosis.  The next chapter describes the study’s participants, 
the data collection procedures within the Summer Treatment Program (STP), 
instrumentation, and the research design including limitations of analyzing the data, 
research questions, and a statistical plan and analysis of data.
63 
CHAPTER III 
METHODOLOGY 
Introduction 
The description of the methodology, in this chapter, is divided into four sections.  
First, the characteristics of the study’s participants are discussed.  The second section 
presents the data collection procedures within the Summer Treatment Program (STP).  
Third, the instrumentation is discussed.  Lastly, the research design including limitations 
of analyzing the data, hypothesis, and a statistical plan and analysis of data is detailed. 
Data Source 
 This research was based on archived data from 1999 - 2012 retrieved from the 
Summer Treatment Program implemented through an ADHD behavioral clinic of a large, 
metropolitan children’s hospital in Northeast Ohio.   
STP Implementation History 
The Summer Treatment Program has been offered throughout the United States 
including: Florida State University (1980-1986), the University of Pittsburgh Medical 
Center (1987-1996), and the State University of New York (SUNY) at Buffalo (1997 to 
present), Canada and Japan.  This intensive treatment program has also been offered as a 
part of further comprehensive treatment packages such as the National Institute of Mental
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Health Multimodal Treatment Study of Children with ADHD and the Early Risers 
Program. To date, the program has been replicated at approximately 30 sites varying 
from mental health agencies, University settings and national hospitals.  Adolescent 
programs of the STP have also been offered throughout the United States as well.  
Numerous studies of child behavior and treatment responses have been conducted within 
the context of the STP. Program efficacy has been evaluated in several studies and 
reviewed by the Substance Abuse and Mental Health Service Administration’s 
(SAMHSA) National Registry of Evidence-based Programs and Practices (NREPP). The 
NREPP has independently assessed and rated the STP as high in quality of research and 
readiness for dissemination (http://www.nrepp.samhsa.gov/ViewIntervention.aspx?id=8). 
Data Collection 
Prior to enrollment and acceptance into the program, parents signed informed 
treatment consent forms which included information about current and future research 
relating to the program. The behavioral clinic granted permission to analyze the archived 
data and the documentation for use of the data can be found in Appendix (A).  Likewise, 
Cleveland State University’s (CSU) Institutional Review Board (IRB) approval was also 
obtained (included in Appendix B). 
 Outcome data from the Summer Treatment Program was retrieved from the 
previously created data set located within the behavioral clinic, which included all 
weekly point totals obtained by every participant throughout the Summer Treatment 
Program.  Additional Summer Treatment Program records, weekly point totals, 
individual treatment summaries and materials were reviewed.  Information related to 
ADHD diagnosis, comorbidity type, demographic and medication information, were 
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collected and analyzed from the Summer Treatment Program to answer the four research 
questions. 
Ensuring Confidentiality 
Steps were taken during the review of archived data to ensure confidentiality.  
Previously collected Summer Treatment Program records, weekly point totals, individual 
treatment summaries and materials were reviewed for the purposes of this dissertation 
within the behavioral clinic.  All dissertation study information related to ADHD 
diagnosis, comorbidity type, demographic and medication information were stripped of 
identifiers and re-coded.  All children’s names were eliminated from the data set and 
given a CSU ID code and numerical values were assigned to the following variables (STP 
year, CSU ID, Program Year, Week/Time, Age, Group, Race, Gender, Primary 
Diagnosis, Comorbidity, Comorbidity Type1, Comorbidity Type2, Comorbidity Type3 , 
Comorbidity Type4, STP Medication, Total weekly Pts).  
Sample 
  During the summers from 1999 - 2012,  participants enrolled in the Summer 
Treatment Program (Summer Treatment Program, Pelham, Greiner et al., 2010) met 
between June through July at various site locations including the campus of a small, 
liberal arts colleges in Northeast Ohio (7 summers),  local suburban elementary schools 
(4 summers), and a Jewish Community Center (3 summers).  Approximately 516 children 
participated in the Summer Treatment Program (STP) sponsored through an ADHD 
specialty clinic of a large, metropolitan children’s hospital in Northeast Ohio. Although 
children may have participated in the program more than one year, for the purpose of this 
dissertation, only first year participants were included.  Children who had more than one 
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exposure generally had a greater advantage and understanding of the nature and 
expectations of the program and would presumably bias the sample. 
The number of participants included in this dissertation research was reduced for 
the following reasons: 140 subjects were removed because they were not first year 
participants, 21 subjects were removed due to age exclusions (1 was 5 years old, 20 had 
no age listed), 10 subjects were removed by primary diagnosis (3 Pervasive 
Developmental Disorder, 1 cyclothymia, 1 Oppositional Defiant Disorder, 1 Mood 
Disorder, 2 No diagnosis, and 2 were missing primary diagnosis.   Also, due to small 
comorbid confirmed diagnoses, children with Comorbid adjustment disorder (1), 
enuresis/encopresis (4), subsyndromal yet clinically significant (8), and other (13) 
comorbidities were excluded from the sample. An encouraging aspect of these data was 
that the overall proportion of missing variables was low. 
A final total of 345 subjects were selected for inclusion in this analysis. Subjects 
had a median age of 8.53 years; were mostly male (77.1 %); predominantly Caucasian 
(70.7 %), and diagnosed ADHD combined and hyperactive/impulsive type (93.6).  Most 
participants had at least one comorbid mental health diagnosis (52.8%), and had taken 
some type of psychotropic medication (82.7%) while in the program.   
The children participating in the summer treatment program were grouped by 
their age, each treatment group consisting of 10 to 14 children, based on each child’s 
birthday.  Although the program also included an adolescent treatment groups, this 
dissertation focused specifically on ages 6 to 12 year olds.  The children’s names were 
not included in this research; the data for this research was information that was collected 
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as standard procedure for participation in the Summer Treatment Program.  For this 
dissertation, children’s data only included the first year participation in the program. 
Recruitment, Screening and Application processes for the STP 
Local education agency’s school personnel, mental health agencies, primary care 
physicians, and social work professionals, as well as individual parents referred children 
for enrollment into the Summer Treatment Program.  Recruitment efforts were conducted 
by local media advertising, such as brochures, informational workshops, and web 
postings.  Parent and Teacher rating scales/assessments, medical-social forms, birth, 
family, and demographic questionnaires were included in application packets and sent via 
US Mail to interested parents.  
Behavioral and emotional rating scales collected from both parents and teachers 
during the application and screening processes included the Achenbach Child Behavior 
Checklist (Achenbach, 1999) and the Teacher Report Form (Achenbach, 1991), the 
DuPaul ADHD Rating Scale-IV (DuPaul, Power, McGoey, Ikeda, & Anastopoulos, 
1998), the Connors (1990, 2002) Abbreviated Symptom Questionnaire (ASQ) and the 
Clinical Global Impressions Scale (Guy, 1976).  These measures were used to assist with 
the confirmation of ADHD diagnosis and acceptance into the summer treatment program.  
Additionally, parents could supply copies of their child’s: Individual Education Plans, 
mental health/psychological diagnostic assessments, and/or evaluations to assist in the 
enrollment process.  Parent and teacher scales/ratings were scored and evaluated to 
confirm primary diagnosis of ADHD and inclusion into the program by the Clinical 
director. If necessary, semi structured interviews with parent and child were necessary for 
inclusion into the program in order to assist with diagnosis confirmation.  These 
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assessments and materials were all collected prior to the children’s participation in the 
summer treatment program, for the program’s purposes, and were not collected for the 
purposes of this research.  The archived records, including weekly point totals, were the 
data source to answer this study’s research questions and for the data analyses.  
STP Inclusion and exclusion criteria 
The records of the children meeting Diagnostic and Statistical Manual of Mental 
Disorders-IV (American Psychiatric Association, 1994) and the Diagnostic and Statistical 
Manual of Mental Disorders IV TR (American Psychiatric Association, 2000) symptom 
criteria for attention-deficit/hyperactivity disorder (ADHD) are the records of interest for 
this dissertation research and necessary for inclusion into the program.  DSM-IV 
attention-deficit/hyperactivity symptoms were rated by parents and teachers using the 
ADHD Rating Scale (DuPaul et al., 1998).  To enroll in the program, participants must 
have been between the ages of 6 and 14 years of age and have met symptom criteria for 
ADHD, either Combined Type, Predominantly Inattentive Type or Predominantly 
Hyperactive-Impulsive Type.  Comorbid mental health diagnoses and psychotropic 
medication use were permitted. Although such diagnostic comorbidities were generally 
allowable, the clinical director at each site may have excluded a child if it was determined 
that the comorbid disorder was primary over the ADHD or that the severity of the 
comorbid disorder would clearly disrupt the treatment (e.g., autism, schizophrenia, 
bipolar disorder or conduct disorder with severe behavioral disruption).  Fees for the 
program were collected and based on the cost of providing intensive daily therapy and 
interventions.  Children who met the program's criteria were offered admission.  
Demographics and descriptive information 
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A description of the children who completed the summer program between 1999 
and 2012 included a) the percentage of children diagnosed with ADHD by subtype, 
namely ADHD-Combined Type, ADHD-Predominantly Inattentive Type, and ADHD-
Predominantly Hyperactive-Impulsive Type, b) percentage of children with comorbid 
disorders by type, c) age, d) sex, and e) race are outlined in Table 1. 
Table 1 
Psychosocial and Demographic Variables: Descriptive Statistics (N=345) 
Variables M SD % 
Age  8.53 1.71  
Number of comorbidities  0.71 0.81  
Race/Ethnicity     
 Caucasian   70.7 
 African American   18.6 
 Hispanic   2.3 
 Asian   2.0 
 More than one selected   6.1 
ADHD diagnosis type     
 Combined/hyperactive/impulsive   93.6 
 Inattentive   6.4 
Diagnosed comorbidity     
 Yes   52.8 
 No   47.2 
Prescribed medication     
 Yes   82.7 
 No   17.3 
Gender     
 Male   77.1 
 Female   22.9 
 
Verification of ADHD Comorbidity  
Application packets and materials, previously completed by parents and teachers 
to rate ADHD symptoms, were required by the program in order for the clinical director 
to confirm diagnoses of ADHD along with any possible comorbidities.  All application 
packets were reviewed by the clinical director prior to offering acceptance into the 
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Summer Treatment Program. The Achenbach Child Behavior Checklist (CBCL; 
Achenbach, 1999) and the Teacher Report Form (TRF; Achenbach, 1991), the DuPaul 
ADHD Rating Scale-IV (ARS-IV; DuPaul, Power, Anastopoulos et al., 1998), the 
Connors (1990, 2002) Abbreviated Symptom Questionnaire (ASQ) and the Clinical 
Global Impressions Scale (CGI; Guy, 1976), were key in the confirmation of ADHD 
diagnoses and comorbidities.  Primary Diagnosis with comorbidity type was then 
transcribed onto a separate form, “ADHD application review and acceptance form”  (see 
appendix C) which was located in every child’s file and co-signed by the Clinical 
Director.   The “ADHD application review and acceptance form” served the purpose of 
confirming that the child met criteria for primary diagnosis of ADHD, listed all 
comorbidities, and verified that the child was accepted into the program.  For the purpose 
of the dissertation, the “ADHD application review and acceptance form” was reviewed 
for ADHD diagnosis and comorbidity type and collected for this research.  
Definition of Comorbid Subgroups 
 Additional diagnostic information was collected and evaluated as part of the STP 
application process, including symptoms of oppositional-defiant disorder (ODD), bipolar 
disorder (BP), conduct disorder (CD), pervasive developmental disorder (PDD), anxiety 
(ANX), obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD) and 
depression (DEP). 
For the purposes of this dissertation research, children were also identified as having 
ADHD alone or as having ADHD with an additional diagnoses (CO1) noting those with 
two diagnoses [CO2], or three [CO3] as outlined in Table 2. 
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Table 2 
Descriptive Statistics of Comorbidity Type (N=345) 
Type N % 
Anxiety disorders (OCD, PTSD) 44 13.0 
Mood disorders (depression, bipolar) 37 10.7 
Opposition defiant disorder 45 13.0 
Pervasive developmental disorders (Asperger’s, autism spectrum 26 7.5 
Tic-Tourette’s 22 6.3 
Learning disorder 42 12.5 
No Comorbidity 163 47.2 
One Comorbidity 33 9.6 
Three Comorbidities 15 4.3 
 
Procedures 
The Summer Treatment Program is a 7-week, intensive summer behavioral 
intervention program designed for children diagnosed with ADHD, aged 6 to 12 years 
old, as well as an adolescent group for ages 12 to 14.  Children aged 6 to 12 years of age 
attended from 8:30 AM to 5:30 PM, Monday through Friday, and adolescents attended 
from 8:00 AM to 5:50 PM weekdays as well.  For the purpose of the dissertation, archival 
data from the adolescent component was not studied.   
Quite similar to a day treatment program, the STP tailors individualized treatment 
goals specific to the needs of each child. Generally, 10 -14 children comprised a 
treatment group with 5 to 6 clinical staff members present.  Groups were facilitated by a 
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graduate level lead counselor and 4 or 5 undergraduate level group counselors. The team 
of group counselors monitored children closely throughout the day, implementing the 
program and recording behaviors.  Prior to working with children, all staff received two 
weeks of intensive training covering the entire program manual.  All staff members and 
counselors hired for the program were required to pass an operational definitions exam 
covering all aspects of the Summer Treatment Program (point system behaviors, lists of 
rules for all activities, hierarchical system for classification of behaviors).   
Throughout the day, children engaged in social skills training, recreational 
activities, and skill drills for the following sports: basketball, softball and soccer, as well 
as swimming.  Children also participated in academic learning centers, instructed by 
elementary school teachers, to strengthen their ability to follow through with instructions, 
attend to and complete tasks, and comply with adults' requests in the classroom (Caserta, 
2008). Academic learning centers were designed similarly to elementary school 
classroom settings and children participated in computer and art instruction by specialty 
teaching staff.  Children and counselors remained in their assigned group throughout the 
summer to build relationships and consistency.  The children spent 3 hours daily in 
learning centers (LC), including an Academic LC, a Computer LC, and an Art LC. 
Again, these classrooms were supervised by developmental specialists (typically special 
education teachers), and developmental aides (undergraduate students).  These staff 
members implemented behavior modification programs designed to treat children's 
problems in a classroom context.  Children spent the remainder of each day engaging in 
recreationally based group activities, while under the supervision of the counselors.  
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Weekly parent training classes and medication assessments were also vital parts 
of the Summer Treatment Program.  One evening a week, each child’s parent/s was 
invited to participate in training sessions held by the clinical director to learn skills and 
strategies to improve the parent-child relationship and behavior management skills for 
home.  Although not required, some parents and children participated in medication trials 
designed to assist the family in evaluating the optimal medication dosage while 
participating in the STP. 
Dependent Variable: Point System and Token Economy 
The point system, or token economy, is a major component of the STP 
intervention, and children earned or lost points contingent upon their behaviors.  Children 
earned points and exchanged them for a variety of rewards, including home and program 
privileges, field trips, and special honors.  The point system served the following two 
primary functions in the STP: 1) one of the main procedures used to increase the 
frequency of appropriate behaviors and to decrease the frequency of undesirable 
behaviors exhibited by the children in treatment and 2) the primary data system for the 
STP.  Accurate recording of positive and negative behaviors provided the clinical staff 
members with the necessary information for developing and monitoring a child’s 
treatment.  In addition to helping determine the nature of the children's behavior 
problems, the data was used to evaluate response to treatment, as significant changes in 
the frequencies of behaviors may reflect positive responses to behavioral treatment.   
This token economy varied slightly as a function of the activities in which the 
children and adolescents participated. Namely, during the four 1-hour, recreational 
activities, children continuously earned points for exhibiting appropriate behaviors and 
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lost points for exhibiting inappropriate behaviors; whereas, during the three classroom 
activities, the behavioral system was less complex and involved a reward and a response 
cost system in which children began each learning center with 100 points and lost 10 
points for each rule violation.  
Throughout the day, staff members recorded the frequency of both positive, 
prosocial behaviors and negative, disruptive behaviors.  There were nine prosocial 
behaviors that were socially desirable and 16 negative behaviors which were undesirable.  
The point system behaviors were operationally defined and mandated whether points 
were awarded or taken away for a specific action or verbalization.  The positive category 
behaviors included: Following Activity Rules, Good Sportsmanship, Behavior Bonus, 
Attention, Compliance, Helping a Peer, Sharing with A Peer, Contributing to Group 
Discussion, and Ignoring a negative stimulus.  The negative category behaviors included: 
Violating Activity Rules, Poor Sportsmanship, Intentional Aggression toward a peer or 
staff member, Unintentional Aggression toward a peer or staff member, Intentional 
Destruction of Property, Unintentional Destruction of Property, Noncompliance, 
Repeated Noncompliance, Stealing, Leaving the Activity Area without permission, 
Lying, Verbal Abuse to Staff, Name Calling/Teasing, Cursing/Swearing, Interruption, 
and Complaining/Whining.  
The daily frequencies of behaviors have been demonstrated to hold validity in 
assessing children’s responses to both behavioral and pharmacological treatments 
(Pelham & Hoza, 1996). Point system behaviors throughout the STP were, therefore, 
used as dependent measures of children’s responses to treatment.  Behavioral data for 
every child was entered into a computer database at the end of the treatment day by two 
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group counselors from each child’s group which allowed for evaluation of the frequency 
with which children exhibited both prosocial and disruptive behaviors.  Means for every 
point system behavior were automatically calculated on a daily basis, which allowed for 
not only the evaluation of specific behavioral changes, but also the speed with which 
children changed such behaviors over time.  For this dissertation, the amount of points 
earned by each child was calculated to show treatment outcomes compared by age, 
gender, and comorbidity type. The more points a child earned therefore reflected more 
appropriate and positive behavior.  The weekly point totals for participants from 1999 to 
2012 ranged from -40910 to 21340 (M=6301, SD=7820).  Weekly point total scores were 
considered the dependent variable for this dissertation. A summary of weekly point totals 
is outlined in Table 3.   
Table 3 
Summary of Total Weekly Points Earned During Weeks 2 – 6 (N=345) 
 
 Missing          N Mean SD Minimum Median Maximum           
Total weekly points       35             1689 6301 
      
7820 
-40910 7585 21340 
 
Treatment Integrity and Fidelity 
The summer treatment program includes treatment integrity and fidelity checks 
and quizzes.  Treatment integrity and fidelity checks were conducted weekly by the 
Clinical Director to ensure that the intervention was implemented as intended. Feedback 
was given to lead counselors, group counselors and teaching staff during the program, as 
well, to prevent serious errors which can occur when interpreting treatment responses.  
Treatment integrity and fidelity checks are an important part of the manualized program 
and designed to maximize Pearson correlations between the observations made by staff 
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members and those made by trained independent observers.  Previous studies have 
demonstrated Pearson correlations above .8 (Chronis et al., 2004).  
In addition, children’s daily point totals were entered in the Summer Treatment 
Program Data base by two staff members to ensure accurate data entry and consistent 
data reliability of the summer treatment program.  Treatment integrity and fidelity was 
critical to both the clinical treatment being offered at the time of the program and for 
further investigation of research projects in the future. 
Daily Report Card 
Although the STP provides a standardized manual for implementation of the 
group treatment, treatment is individualized for each child through the development of a 
Daily Report Card (DRC).  Children’s behaviors were monitored during the first week of 
the program in order to identify target behaviors that were creating the most significant 
impairment.  After identifying these individualized, target behaviors, staff members 
calculated the child’s daily average instances of each behavior and set a goal for the child 
to reach at the start of the second week of the program.  Target goals would be adjusted 
based on their lack of success, whereby the goals may have actually been increased (for 
negative behaviors) or decreased (for positive behaviors) in order to continuously allow 
the child to succeed with a target goal. Children that met 75 percent of their daily report 
card during the week could earn a weekly field trip reward on Fridays. The weekly 
success of the daily report card is an important component of the summer treatment 
program; however due to the variability of each child’s target goals, the success was not 
utilized as an indicator of the rate of change for this dissertation. 
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Treatment Outcomes 
For this dissertation, treatment outcomes were measured by the rate of change for 
age groups, gender, and  comorbidities.  The dependent measures included an analysis of 
the point system behaviors recorded during the program from baseline to end of 
treatment.  For the purposes of this dissertation research, treatment outcomes were 
assessed via the point system behaviors from weeks 2 through 6.  The first week of the 
program is generally considered the “honeymoon” and the last week of the program 
considered the “termination week.”  Children’s weekly scores during weeks 1 and 7 were 
not true indications of their individual responses to treatment.  Similarly, the program 
completed individual treatment reports detailing each child’s individual daily report card 
treatment outcomes based on Weeks 2 through 6.  Therefore, similar to the program’s 
individual treatment summary reports, this dissertation focused on treatment outcomes of 
the 14 years of data from program weeks 2 through 6, as well. 
Analyses and Statistics  
 For the purposes of this dissertation research, linear mixed effects regression 
analysis was selected.  Mixed-effects regression models are advantageous relative to 
standard repeated-measures analysis of variance because of their ability to accommodate 
missing data (not all archival data was captured due to some incomplete values (e.g. some 
children missed a week of data for vacation purposes and subjects not finishing program) 
to explicitly model relationships between repeated measures (rather than assuming 
sphericity), and to directly model the effects of time (Manos et al.; 2012). 
Numerical measures were summarized by median and interquartile range. 
Categorical variables were summarized by frequency and percentage.  Univariable 
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comparisons by comorbidity status were performed, utilizing Wilcoxon's rank sum test, 
and chi square tests.  The test use was denoted in the output, see Table 4. 
Table 4 
Comparison of Subject Descriptors by Comorbidity Status 
  No Yes  
Factor Total N Statistics N Statistics p-value 
Age  
a
 345 163 8 [7, 10] 182 8 [7, 10] 0.055
W
 
Race  
b
 345         0.51
C
 
  Caucasian 244 112 45.9 132 54.1   
 
 
  Other 101 51 50.5 50 49.5   
 
 
Gender  
b
 345         0.42
C
 
  Female 79 41 51.9 38 48.1   
 
 
  Male 266 122 45.86 144 54.14   
 
 
Age Group  
b
 345         0.13
C
 
  1 125 69 55.2 56 44.8   
 
 
  2 96 39 40.62 57 59.38   
 
 
  3 108 49 45.37 59 54.63   
 
 
  4 16 6 37.5 10 62.5   
 
 
a
 Median [P25, P75]; 
b
 Percentage 
C: Pearson's Chi-squared test with Yates' continuity correction 
W: Wilcoxon rank sum test with continuity correction 
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Table 4 (continued) 
Comparison of Subject Descriptors by Comorbidity Status 
    No 
 
 Yes  
Factor Total N Statistics N Statistics p-value 
Summer treatment program year  
b
 345         0.54
C
 
  1999 38 17 44.74 21 55.26   
 
 
  2000 20 10 50 10 50   
 
 
  2001 28 16 57.14 12 42.86   
 
 
  2002 21 7 33.33 14 66.67   
 
 
  2003 21 8 38.1 13 61.9   
 
 
  2004 27 11 40.74 16 59.26   
 
 
  2005 22 6 27.27 16 72.73   
 
 
  2006 22 10 45.45 12 54.55   
 
 
  2007 29 13 44.83 16 55.17   
 
 
  2008 25 14 56 11 44   
 
 
  2009 23 13 56.52 10 43.48   
 
 
  2010 27 15 55.56 12 44.44   
 
 
  2011 21 10 47.62 11 52.38   
 
 
  2012 21 13 61.9 8 38.1   
 
 
a
 Median [P25, P75]; 
b
 Percentage 
C: Pearson's Chi-squared test with Yates' continuity correction 
W: Wilcoxon rank sum test with continuity correction 
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Total weekly points were modeled using linear mixed effects methods with 
comorbidity status, age, gender, and race as independent variables.  Whereas the data 
were relatively balanced (the same number of observations per subject), 95% confidence 
intervals and p-values were calculated from normal standard errors. Subject ID was 
entered as the random effect and evaluated by visual inspection of plots and a likelihood 
ratio test. Additional models for weekly points were developed to evaluate the 
relationship of specific comorbidities on weekly points.  Treatment outcomes are reported 
based on results from weeks 2 through 6 of the Summer Treatment Program.  A linear 
mixed effects methods analysis was conducted with the dependent measures for the age 
group, comorbidity, and gender comparisons to test all four research questions (see 
Appendix D). The research questions are as follows: 
1. Do children diagnosed with ADHD alone, who attend an intensive 
summer treatment program, differ in treatment outcomes from those 
children diagnosed with ADHD comorbidity? 
2. Do males diagnosed with ADHD comorbidity, who attend an intensive 
summer treatment program, differ in treatment outcomes from females 
with ADHD Comorbidity? 
3. Are there age group differences in treatment outcomes with children 
diagnosed with ADHD comorbidity who attend an intensive summer 
treatment program?   
4. Do children with different comorbid diagnoses and ADHD, who attend an 
intensive summer treatment program, differ in treatment outcomes?  
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Conclusion 
Over a fourteen year period, from 1999 -2012, the collection of data from the 
Summer Treatment Program (STP) offered through an ADHD specialty clinic of a large, 
metropolitan children’s hospital in Northeast Ohio, offered this researcher an opportunity 
to analyze the aforementioned research questions.  This chapter provided specific 
information about the STP participants, the program, the procedures, instruments, and the 
data analyses.  Chapter Four provides the results of the linear mixed effects methods 
analysis performed on all four research questions.
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CHAPTER IV 
RESULTS 
 This chapter is organized around the sequence of the research questions.  Each 
question is stated and followed by the results of the analyses.  The tables of the output are 
given to assist with explanation of the findings. 
Research Question 1 
Do children diagnosed with ADHD alone, who attend an intensive 
summer treatment program, differ in treatment outcomes from those 
children diagnosed with ADHD comorbidity? 
No, the children diagnosed with ADHD alone did not differ in treatment 
outcomes from those with ADHD Comorbidity.  Week two mean predicted score of the 
comorbidity group was lower than in the no comorbidity group (5673.95 compared to 
6057.71, respectively).   This pattern was also true for week 6, although the difference 
increased very slightly (7808.50 compared to 8192.27, in the comorbidity and no 
comorbidity groups, respectively), as outlined in Table 5. 
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Table 5:  
Predicted Weekly Scores in No Comorbidity vs. Comorbidity by Week (N=345) 
Program Week ADHD Alone ADHD with Comorbidity 
2 6057.71 5673.93 
3 6821.24 6437.47 
4 7439.75 7055.98 
5 7754.64 7370.88 
6 8192.27 7808.50 
 
In both groups, predicted weekly scores showed consistent improvement from 
week two through week six.  While the children with at least one comorbid diagnosis 
scored consistently lower than their ADHD alone counterparts, they appeared to have a 
similar relative benefit to their baseline scores.  Over the course of the program, it was 
estimated that children with comorbidities would score an average of -375.24 points 
lower than children with ADHD alone.  This difference was not statistically significant 
(Beta = -375.24; T = -0.60; df = 331; p = 0.55), see Table 6.   
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Table 6:  
Linear Mixed Effects Model Summary for Total Weekly Points and Comorbidity 
Factor  Level     Beta  95% Confidence Interval  T      P-value  (T)  
(Intercept)  
 
319.3  (-3380.19, 4018.81)  0.17  0.87  
Comorbidity  Yes vs. No  -375.2  (-1598.07, 847.59)  -0.60  0.55  
Week/time  3 vs. 2  771.3  (183.11, 1359.44)  2.57  0.01  
 
4 vs. 2  1385.5  (804.38, 1966.61)  4.68  < 0.001  
 
5 vs. 2  1698.6  (1115.54, 2281.62)  5.71  < 0.001  
 
6 vs. 2  2140.7  (1555.3, 2726.15)  7.17  < 0.001  
Age  
 
781.5  (419.4, 1143.61)  4.23  < 0.001  
Race  Other vs. Caucasian  -301.7  (-1666.69, 1063.36)  -0.43  0.66  
Gender  Male vs. Female  -1382.8  (-2866.02, 100.38)  -1.83  0.068  
Medications 
during STP 
Yes vs. No  -718.9  (-2351.16, 913.3)  -0.86  0.39  
 
Additionally, an interaction between comorbidity status and week was 
investigated. The presence of such an interaction would indicate that change in total 
weekly scores develop at different rates in the comorbidity and ADHD alone groups 
across time (e.g., non parallel slopes). Results reported in the ANOVA table showed no 
overall effect for this interaction, suggesting that the interaction may be left out of the 
model (F = 1.06; num. df = 4, den. df = 331; p = 0.38). See Table 7. 
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Table 7 
Analysis of Variance Table: Comorbidity and Week Interaction 
 Df   Sum Sq Mean Sq F value     P 
Comorbidity 1  6.13e+05 6.13e+05 0.04 0.839 
Week.Time_factor     4  9.29e+08 2.32e+08    15.77 0.000 
Age   1  2.95e+08 2.95e+08    20.03 0.000 
Race2 1  1.32e+05 1.32e+05     0.01 0.925 
Gender 1 4.81e+07 4.81e+07     3.27 0.072 
STP.Med                  1 1.10e+07 1.10e+07     0.74 0.389 
Comorbidity:Week.Time_factor               4 6.22e+07 1.55e+07     1.06 0.378 
Comorbidity:Age    1 1.98e+07 1.98e+07     1.34 0.247 
Week.Time_factor:Age 
   
4 1.70e+08 4.25e+07     2.89 0.023 
Comorbidity:Gender    
  
1 1.02e+07 1.02e+07     0.69 0.406 
Comorbidity:Week.Time_factor:Age               
 
4 6.80e+07 1.70e+07    1.15 0.331 
 
Research Question 2 
Do males diagnosed with ADHD comorbidity, who attend an intensive 
summer treatment program, differ in treatment outcomes from females 
with ADHD comorbidity? 
Yes, the males diagnosed with ADHD comorbidity did differ in treatment 
outcomes from females.  Week two mean predicted score for females was higher than for 
males (8126.83 vs. 5819.17, respectively).  This pattern was also true for week 6 
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(10672.22 compared to 8364.55, in the females and males, respectively), as outlined in 
Table 8.  
Table 8 
Predicted Weekly Scores for Female Comorbidity vs. Male Comorbidity by Week (N= 
182) 
Program Week Female Comorbidity   Male Comorbidity 
2 8126.83 5819.17 
3 9321.69 7014.03 
4 9645.69 7338.03 
5 10284.03 7976.37 
6 10672.22 8364.55 
 
In both genders, predicted weekly scores showed consistent improvement from 
week two through week six. While males scored consistently lower than females, they 
appear to have a similar relative benefit to their baseline scores. Over the course of the 
program, it is estimated that males will score an average of -2307.66 lower than females. 
This difference is statistically significant (Beta = -2307.66; T =-2.08; df = 170; p = 
0.038), see Table 9.   
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Table 9 
Linear Mixed Effects Model Summary for Total Weekly Points and Gender Comorbidity 
Factor  Level  Beta  95% Confidence Interval  P-value (T)  
(Intercept)  
 
1592  (-3744.06, 6928.29)  0.56  
Week/time  3 vs. 2  1195  (411.77, 1977.96)  0.003  
 
4 vs. 2  1519  (745.36, 2292.38)  < 0.001  
 
5 vs. 2  2157  (1380.24, 2934.17)  < 0.001  
 
6 vs. 2  2545  (1771.88, 3318.9)  < 0.001  
Age  
 
1495  (-24.89, 3013.93)  0.054  
Race  Other vs. Caucasian  -1063  (-3044.29, 918.9)  0.29  
Gender  Male vs. Female  -2308  (-4483.72, -131.6)  0.038  
Medications during STP  Yes vs. No  1033  (-1310.99, 3376.48)  0.39  
 
Research Question 3 
Are there age group differences in treatment outcomes with children 
diagnosed with ADHD comorbidity, who attend an intensive summer 
treatment program? 
No, there were not age group differences in treatment outcomes with children 
diagnosed with ADHD comorbidity.  Week two mean predicted score for six year olds 
was lower than 12 year olds (4075.56 compared to 7064.60, respectively). This pattern 
was also true for week 6 (6620.95 compared to 9609.99, in the 6 year olds and 12 year 
olds, respectively), see Table 10. 
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Table 10 
Predicted Weekly Scores for Age of Participants by Week (N=182) 
Week Age 6 Age 7 Age 8 Age 9 Age 10 Age 11 Age 12 
2 4075.56 4573.73 5071.90      5570.08        6068.25         6566.43       7064.60 
3 5270.42            5768.60 6266.77 6764.94 7263.12          7761.29      8259.46 
4 5594.43 6092.60 6590.77   7088.95        7587.12          8085.29       8583.47 
5 6232.76   6730.94 7229.11   7727.29        8225.46         8723.63       9221.81 
6 6620.95  7119.12 7617.29    8115.47         8613.64         9111.81      9609.99 
 
In all ages, predicted weekly scores showed consistent improvement from week 
two through week six. While younger participants scored consistently lower than older 
participants, they appeared to have a similar relative benefit to their baseline scores. Over 
the course of the program, it was estimated that each year of increased age associated 
with an increase of 1494.52 points. The effect of age on weekly score was cumulative. 
Although this difference was not statistically significant (Beta = 1494.52; T = 1.93; df = 
170; p = 0.054; as outlined in Table 11), the general trend shows that a seven year old 
would be expected to score 1494.52 more points than a six year old, and that an eight 
year old would score 2989.04 more points than the six year old, as the effect on weekly 
score is cumulative. 
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Table 11 
Linear Mixed Effects Model Summary for Total Weekly Points and Age 
Factor  Level  Beta  95% Confidence Interval  P-value (T)  
(Intercept)  
 
1592  (-3744.06, 6928.29)  0.56  
Week/time  3 vs. 2  1195  (411.77, 1977.96)  0.003  
 
4 vs. 2  1519  (745.36, 2292.38)  < 0.001  
 
5 vs. 2  2157  (1380.24, 2934.17)  < 0.001  
 
6 vs. 2  2545  (1771.88, 3318.9)  < 0.001  
Age  
 
1495  (-24.89, 3013.93)  0.054  
Race  Other vs. Caucasian  -1063  (-3044.29, 918.9)  0.29  
Gender  Male vs. Female  -2308  (-4483.72, -131.6)  0.038  
Medications during STP  Yes vs. No  1033  (-1310.99, 3376.48)  0.39  
 
Research Question 4 
Do children with different comorbid diagnoses and ADHD, who attend an 
intensive summer treatment program, differ in treatment outcomes? 
Only one comorbid diagnosis was associated with statistically significant 
differences in weekly scores.  Specifically, children with ADHD and ODD earned 
significantly fewer points than children with ADHD only. Children with this comorbid 
diagnosis earned 2048.7 fewer points than those with no comorbidities. This difference in 
scores ranged from -4015.76 to -81.64 points. These results did demonstrate statistical 
significance (Beta = -2048.7; T = -2.0438; df = 198; p = 0.041).  All other comorbid 
diagnoses examined in this analysis were not associated with differences in treatment 
outcomes when compared to children with no comorbidities.  Interestingly, among all 
children with at least one comorbidity, children with learning disorders had the highest 
mean weekly scores (7909.00), while children diagnosed with ODD scored the lowest 
(3973.00), see Table 12.  
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Table 12 
Mean Summary of Weekly Scores by Number of Comorbidities and Type  
 
Number of 
Subjects  
Mean Weekly 
Score 
Mean Second 
Week Score 
Mean Sixth 
Week Score 
No comorbidities 163 6385 5459 7272 
One comorbidity 131 6202 4968 7229 
Two comorbidities 33 6508 4642 7946 
Three comorbidities 15 5821 4080 6390 
Anxiety D/O, OCD, PTSD 44 6474 5511 7496 
Mood 37 6449 4128 7802 
ODD 45 3973 3446 4438 
PDD, aspergers, autism 
spectrum 26 4780 2488 5763 
Tic-Tourettes 22 6661 4325 8068 
Learning disorder 42 7909 6261 9407 
 
Children with comorbid anxiety scored 734.27 lower than children with ADHD 
alone, though this difference may range from -2613.69 to 1145.16 points.  The difference 
associated with an anxiety comorbidity was not statistically significant (Beta = -734.27; T 
= -0.7667; df = 198; p = 0.44).  Children with mood comorbidities scored 394.44 lower 
than subjects with ADHD alone, though this difference may range from -2366.29 to 
1577.4 points. The difference associated with a mood comorbidity was not statistically 
significant (Beta = -394.44; T = -0.3926; df = 190; p = 0.69).  Children with any one 
comorbid diagnoses scored 358.02 lower than children with ADHD alone; children with 
two comorbid diagnoses scored 189.46 higher and those with three comorbidities scored 
843.59 lower than those with no comorbidities.  None of these comparisons, however, 
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demonstrated statistical significance (Beta1 = -358.02; T1 = -0.5346; df1 = 335; p1 = 
0.59: Beta2 = -189.46; T2 = -0.1726; df2 = 335; p2 = 0.86:Beta3 = -843.59; T3 = -
0.5461; df3 = 335; p3 = 0.59:)  It would appear that, although the pathologies and 
symptomatic behaviors of the various comorbidities differed, the treatment program 
showed similar results over all of the diagnoses and may be of benefit to children with 
any of these comorbid diagnoses, see Table 13.  For complete model summaries of linear 
mixed effects for each comorbidity type and total weekly scores, see Appendix E.  
Table 13 
Linear Mixed Effects Model Summary for Total Weekly Points and Comorbidity  
                    Factor Level Beta SE Lower Upper T 
P-value 
(T) 
Anxiety D/O, OCD, 
PTSD Yes vs. No -734.3 957.8 -2613.7 1145.16 -0.7667 0.44 
Mood Yes vs. No -394.4 1004.8 -2366.3 1577.40 -0.3926 0.69 
ODD Yes vs. No -2048.7 1002.4 -4015.8 -81.64 -2.0438 0.041 
PDD, aspergers, 
autism spectrum Yes vs. No -1145.0 1212.6 -3524.8 1234.86 -0.9442 0.35 
Tic-Tourettes Yes vs. No 532.2 1274.7 -1969.5 3033.85 0.4175 0.68 
Learning disorder Yes vs. No 884.0 921.4 -924.1 2692.02 0.9594 0.34 
Number of 
Comorbidities 1 vs. 0 -358.0 669.7 -1671.6 955.53 -0.5346 0.59 
 
2 vs. 0 -189.5 1098.0 -2343.0 1964.08 -0.1726 0.86 
 
3 vs. 0 -843.6 1544.8 -3873.6 2186.44 -0.5461 0.59 
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Summary 
This chapter presented the analyses for each of the four research questions.   
Overall findings suggest that the total weekly points did not differ by comorbidity status, 
in that subjects with comorbid diagnoses demonstrated the same improvement in scores 
as subjects without additional comorbidities. Males had significantly lower total scores 
than females; however, while older subjects scored consistently higher than younger 
subjects, these differences were not significant.  Children with a dual diagnosis of ADHD 
and ODD were the only children with comorbidities who evidenced significantly lower 
total points compared to children with no comorbidities. Furthermore, weekly scores 
were shown to improve steadily from week two through week six. 
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CHAPTER V 
DISCUSSION 
This chapter presents a discussion of the dissertation results. After the results for 
each research question are presented along with a general discussion, the implications 
that follow from the findings are explicated. Then, a discussion of the possible limitations 
of this study is outlined. Finally, this chapter ends with recommendations for future 
research and a general conclusion statement.  
Discussion of Results per Research Question 
Research question one.  Children diagnosed with ADHD alone, who attended an 
intensive summer treatment program, did not differ in treatment outcomes from those 
children diagnosed with ADHD and at least one comorbid mental health diagnosis. When 
comparing average total points earned during each week of the STP, while children with 
ADHD only began and ended the program earning more points than children with ADHD 
plus comorbidity, these differences were not statistically significant. In both groups, 
average weekly point totals improved consistently from week two through week six. This 
demonstrates the efficacy of the STP for all children diagnosed with ADHD regardless of 
the presence of a dual diagnosis. 
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One interesting finding involved the lack of an interaction effect between the 
presence of comorbidity and week of the program. Children who do not demonstrate 
positive responses to the basic behavioral program are typically placed on an 
Individualized Treatment Plan (ITP), and children with comorbidities are usually those 
requiring individualized treatment. Given that an ITP is usually implemented only after 
sufficiently illustrating that the regular elements of the STP are not resulting in positive 
behavioral changes, an ITP is typically not initiated until the third or fourth week of the 
program. As such, it may have been predicted that children with comorbidities would 
take longer into the 7-week program to show positive responses. The lack of an 
interaction effect, therefore, may provide evidence that the process of implementing ITPs 
levels the proverbial playing field for children with ADHD and significant comorbidities 
Research question two. Among males and females diagnosed with ADHD and a 
comorbid mental health issue, males were out performed by females and therefore 
differed in their treatment outcomes. Unlike the results of the first research question, 
when comparing average total points earned during each week of the STP, the differences 
in points earned were statistically significant, and females earned more points than their 
male counterparts. While females with ADHD comorbidity began and ended the program 
earning more points than males with ADHD comorbidity, the average weekly point totals 
of both genders improved consistently from week two to week six. The finding that 
females consistently earned more points than males is interesting when considering the 
prevalence rates of ADHD generally and which subtype of ADHD is most common 
among girls versus boys.  
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While the male-female ratio of the sample (3.5:1) was comparable to the ratios 
estimated in the DSM-IV-TR (2:1 to 9:1; American Psychiatric Association, 2000), one 
variable not included in these analyses involved ADHD diagnostic subtype by gender. 
This may be relevant in that females are more commonly diagnosed with ADHD 
Predominantly Inattentive Subtype than males, who are most often diagnosed with 
ADHD Combined Subtype or ADHD Predominantly Hyperactive/Impulsive Subtype 
(American Psychiatric Association, 2000). In this sample, of the 79 female subjects, 10% 
(n=8) had a primary diagnosis of ADHD Predominantly Inattentive Subtype, whereas 14 
of the 266 male subjects (5%) had a primary diagnosis of ADHD Predominantly 
Inattentive Subtype. As such, this difference may have accounted for the finding that 
males earned fewer points overall than females. Here, it would be expected that children 
with primarily inattentive symptoms, as compared to those with primarily hyperactive 
and impulsive symptoms, would exhibit fewer rule violations overall and, therefore, 
would lose fewer points during the treatment program. 
Research question three. While there were age group differences in treatment 
outcomes with children diagnosed with ADHD comorbidity, the differences were not 
statistically significant. Results from this dissertation illustrated that older children earned 
more points on average than younger children. This finding is consistent with previous 
research (Manos, et al. 2012) that suggests older children enrolled in the STP exhibit 
more positive and less negative behaviors than younger children. The normative behavior 
data collected by Pelham et al. (1998) demonstrated that even children without a 
diagnosis of ADHD show a similar developmental trend, in that older children (i.e., ages 
10-12) exhibit fewer negative behaviors (e.g., violating activity rules, interruption, poor 
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sportsmanship) and more positive behaviors (e.g., helping, sharing, ignoring) than 
younger children (i.e., ages 7-10). Therefore, given that children earn points for positive 
behaviors and lose points for negative behaviors, it is not surprising that younger subjects 
were found to earn significantly fewer total points on average as compared to older 
subjects.      
Research question four.  With the exception of children dually diagnosed with 
ADHD and ODD, children with other comorbid diagnoses and ADHD, who attended an 
intensive summer treatment program, did not differ in treatment outcomes as measured 
by total average points earned. Therefore, the overall findings suggested that total weekly 
points neither differed by comorbidity types nor number of comorbidities. Similarly, the 
number of diagnosed comorbidities did not significantly affect children’s earned total 
average points. Furthermore, weekly scores were shown to improve steadily from week 
two through week six, regardless of presence or number of comorbidities. Similar to the 
findings of the first research question, regardless of the number of comorbidities, 
children’s average weekly point totals improved consistently from week two through 
week six, which again provides further support for the efficacy of the STP.  
Interestingly, extant research has demonstrated that one of the most common 
ADHD comorbidities is ODD (Efron & Schibberas, 2010). Given this finding, combined 
with the fact that children with ODD exhibit significantly more clinical oppositionality 
than children with ADHD only, it is not surprising that the participants in this study with 
ADHD plus comorbid ODD earned the fewest amount of total points compared to 
children with other ADHD comorbidities, which was statistically significant. 
Additionally, it is also important to consider the influence of group interactions and group 
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composition as it relates to the findings.  In this dissertation, children with ADHD and 
ODD comprised the greatest number of subjects with ADHD comorbidity.  Again, given 
the finding that children dually diagnosed with ADHD and ODD scored significantly 
fewer points, the findings are consistent with similar research (Macgowan & Wagner, 
2005) which suggests groups with higher percentages of children with disruptive 
behavior disorders (such as conduct disorder and ODD) display greater antisocial 
behavior in groups.  
Another interesting finding is that children diagnosed with ADHD plus LD 
consistently earned more points than children diagnosed with ADHD plus any other 
comorbidity. This supports previous research that found that girls diagnosed with ADHD 
and LD have few behavioral problems relative to those with a diagnosis of ADHD only 
(Marks et al., 2002). Furthermore, given the clinical difficulties involved in 
differentiating symptoms associated with ADHD versus those associated with LD, this 
finding may provide evidence that children with learning disabilities may be improperly 
diagnosed with comorbid ADHD. Consider, for example, a child with a reading disorder 
who avoids homework, has difficulty focusing on homework, and needs almost constant 
redirection during academic tasks. Without the extensive psychological testing that is 
required in order to confirm ADHD symptoms across multiple domains, this type of child 
may incorrectly be labeled as ADHD Predominantly Inattentive Subtype.  
Implications/Suggestions for Future Research 
This research is important for several reasons.  It suggests that clinicians 
providing intensive behavioral treatments like the STP may include children with ADHD 
only and those with ADHD and most comorbidities without fear that the latter group of 
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children will not benefit. Future research, however, should explore other mediating 
and/or moderating factors that may account for positive outcomes of children diagnosed 
with ADHD and other comorbidities. For example, by comparing children in the STP 
diagnosed with ADHD alone to children with multiple diagnoses or comorbidities, better 
treatment matching may be gained and may also reduce some of the clinical uncertainty 
that exists in the literature with regard to treatment options. Certainly, these potential 
findings may lead to additional research and treatment studies, as well as provide support 
for the clinical process of matching patients to treatment in the future. Also, children 
diagnosed with ADHD, including those with comorbidity, show improvement when 
enrolled in a comprehensive treatment program like the STP. Although in some cases the 
findings were not statistically significant based on the key dependent variable (i.e., total 
average points earned each week), the findings did reveal that clinically meaningful 
changes were made by the children enrolled in the STP. If a child is able to increase his 
or her average total points earned week to week, then it would be evidence of clinical 
improvement. More importantly, these findings indicate that the comprehensive 
interventions offered by the STP resulted in similar clinical outcomes regardless of 
gender, comorbidity type, and comorbidity number.  
The near significant difference found across age may have important clinical 
implications for practitioners working with children diagnosed with ADHD via positive 
behavioral programming, especially when considering a patient’s developmental and 
chronological age. Developmentally, older children may be more likely to shape their 
behaviors under the type of positive behavioral contingencies offered in the STP given 
the greater importance that they place on social acceptance. Additionally, the amount of 
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an individual’s social awareness has been demonstrated to be maturational in nature, and 
this finding is present with or without a diagnosis of ADHD. In other words, as all 
children develop, they become more socially aware and, therefore, are more likely to 
adapt their behavior to fit the situation. This finding may be even more pronounced in 
children diagnosed with ADHD, who often lag behind their similar-aged peers from a 
social-developmental perspective. In the same manner, when planning for behavioral 
interventions, practitioners may anticipate the need to manage more challenging and 
disruptive behaviors from children diagnosed with ADHD plus ODD relative to their 
ADHD only counterparts. Once again, findings indicated that children with ADHD plus 
ODD earned fewer overall points, which suggests that they may present with more 
negative behaviors and therefore require more clinical attention.  
Future research may also focus on treatment outcomes for children who return for 
multiple years to the STP, as compared to just one year. No such research has been 
conducted to date. It may be hypothesized that children who return for additional years of 
the summer treatment program would show significant differences in treatment outcomes 
compared to those who attend only one time. Specifically, multiple exposures to the STP 
may result in more improvement year to year. However, there may also be a plateau 
effect expected, such that children who return for several consecutive years fail to make 
additive gains year to year. Clinically, this would be invaluable information for 
practitioners to share with parents, teachers, and providers who may be struggling with 
the important decision of whether to reenroll their child, student, or patient for another 
year or years. Possible variables to explore within this research question include baseline 
severity of ADHD, parent sense of competence, treatment adherence (both parent and 
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child), and family resources. All of these factors may influence not only a child’s need to 
return for another round of treatment, but also a family’s ability to do so.    
Finally, when considering the value of an intensive treatment program such as the 
STP, future studies may explore not only the clinical implications for children with 
comorbid ADHD, but may focus on the practical implications including the transfer of 
treatment  and generalizability of treatment gains to both the home and school settings for 
parents and educators.  As related to the home setting, future study may look at treatment 
outcomes based on the level of parent involvement as possibly measured by the number 
of parent training sessions and booster trainings attended by the parents of children with 
comorbid ADHD.  It may be hypothesized that children whose parents attended and fully 
participated in the STP training and booster sessions would show significant differences 
in treatment outcomes compared to those whose parent/s that did not.  Home assessments 
could also be developed to assess generalizability of STP behaviors to the home 
environment.  
Future study may also explore the relationship between children attending an 
intensive behavior program and academic achievement.  Possible variables to explore 
within this future research question include: total STP points earned, school behavior 
reports, school suspension/expulsion data, and academic grades. Ultimately this future 
research may shed light onto the efficacy of an intensive behavior treatment program 
when transferred to the school settings.  For parents and teachers working with or who 
have children with ADHD comorbidity, the questions and answers learned would be 
valuable information. 
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Limitations 
Just as this chapter acknowledged implications, limitations do exist. For example, not 
controlling for the program year, site location, and the use of psychotropic medication 
and status in the analyses could be viewed as limitations. First, due to the fact that the 
Summer Treatment Program was manualized and contained ongoing fidelity checks, it is 
understood that the quality and content of the program was constant from year to year 
and therefore the program year was not controlled for.  Similarly, it was assumed that 
there were no systematic differences between site locations and the quality and content of 
the site locations were similar from year to year, therefore site location was not controlled 
for.  Psychotropic medications were not controlled for in this dissertation as well.  The 
focus of this dissertation was on the outcomes of children with ADHD enrolled in an 
intensive behavioral program by age, gender, and comorbidity regardless of whether they 
were prescribed psychotropic medication. While researchers may wish to further examine 
the impact of medications, extant research has already demonstrated the efficacy of both 
medication only (American Academy of Child and Adolescent  Psychiatry, 2007) and 
behavioral only treatment for ADHD.(Pelham & Fabiano, 2008) Combined treatment 
(i.e., implementing medication and behavioral treatment concurrently; American 
Academy of Pediatrics, 2001) continues to be the gold standard of care in the treatment of 
ADHD, and whether or not combined treatment resulted in more improvement was not 
one of the research questions of this study.  
Another limitation involves the fact that this sample included data collected 
during two STP years that involved research studies carried out within the context of the 
program. In one study conducted by Fabiano et al. (2004), the time-out procedures 
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utilized to manage more severe behaviors (e.g., repeated noncompliance, intentional 
aggression, and intentional destruction of property) were varied in order to determine 
their efficacy. In the other study conducted by Pelham et al. (2005), some children 
participated in a multi-site, double-blind trial that involved various doses of a transdermal 
methylphenidate patch and placebo. Data collected during such summers were not 
excluded from this analysis. As part of the typical treatments available to all children in 
the STP, parents were given the option to enroll their children in double-blind, 
psychostimulant medication trials with or without placebo. Unlike the aforementioned 
research trials, the medication trials were offered as a clinical service to parents of 
children who were naïve to medication management. Parents and STP staff members 
completed rating scales to determine a child’s response to and tolerability of varying 
doses of medication and, when appropriate, compared to a placebo. In all three of these 
instances, the archival database utilized for the present analyses did not include variables 
that would identify children who may have participated. Therefore, it was neither 
possible to exclude such participants, nor control for them in the models.  
Demographically, the participants in this dissertation represent a more 
homogeneous group lacking a robust ethnically and socio-economically diverse pool.  
Likewise the archived data was from middle to higher socio-economic classes and from a 
largely Caucasian racial background; therefore, inferences made or findings that are 
applied to the general ADHD comorbidity population must be done with caution.  
Another limitation lies within the comprehensive treatment program itself. It was not 
possible to identify children in the program for whom ITPs were developed, and, 
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therefore, future research may benefit from including this information so that a direct 
analysis can be conducted.   
Another possible limitation involves the screening process used for acceptance 
into the STP, whereby children with more severe comorbidities may have been screened 
out. This may have resulted in the lack of finding a significant difference between the 
ADHD only and the ADHD Comorbidity groups (i.e., Type II error). Additionally, this 
may have important clinical implications for future practice, as it would be beneficial to 
better understand the impact that a child’s comorbidity severity may have on positive 
outcomes. Additionally, quite similar to research question #1, and with the exception of 
ODD, the absence of significant differences across other comorbidities in research 
question #4 may have been impacted by the screening process, whereby children with 
more severe expressions of mood, conduct, PDD, etc. were screened out of the STP. Had 
these children been accepted into the STP and included in these analyses, differences may 
have been uncovered, and researchers are encouraged to investigate this further. 
Finally, a highly intensive intervention is quite structured and costly, and the program 
is often difficult to replicate. Therefore, generalizing the positive results of the STP 
treatment to the home and other school settings may be difficult. However, with the 
current push for practitioners and teachers to utilize evidence-based treatments, more 
studies ought to be conducted in naturalistic settings that incorporate certain elements of 
the STP. This may allow for stronger claims of generalizability. 
Conclusion 
This dissertation has moved toward answering important questions regarding 
treatment outcomes for children diagnosed with ADHD and comorbid diagnoses. Both 
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children diagnosed with ADHD and those with ADHD plus a dual diagnosis showed 
improvements over the course of the 7-week Summer Treatment Program, as children in 
both groups earned more points from weeks two to six. By examining 14 years of 
archival treatment data, this research provides additional support for treatment matching 
of children with ADHD regardless of their gender, age, or presence of comorbidity. This 
dissertation also provides evidence of the clinical utility of the STP for children 
diagnosed with ADHD. Given that ADHD comorbidity is almost the rule rather than the 
exception, this study provides additional support for the efficacy of the STP regardless of 
the presence, type, or number of comorbidities.  
In closing, one of the most common arguments against a manualized program like the 
STP involves its lack of individualization. Those who argue against manualized 
treatments suggest that such programs do not allow clinicians to adjust treatment in order 
to meet the needs of their patients. However, the results of this dissertation suggest that 
efficacious, manualized programs actually include individualized treatment as a core 
component. Although highly regimented in its design and implementation, the STP 
allows for the type of adjustment that is required based on each patient’s unique needs.   
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STATISTICAL METHODOLOGY 
 
Research Questions Variables Statistical Analysis 
Do children diagnosed with ADHD 
alone, who attend an intensive 
summer treatment program, differ in 
treatment outcomes from those 
children diagnosed with ADHD 
comorbidity? 
Dependent 
STP point system 
Rate of change 
Independent 
ADHDType 
Comorbidity type 
Linear Mixed Effects 
Methods 
Do males diagnosed with ADHD 
comorbidity who attend an intensive 
summer treatment program, differ in 
treatment outcomes from females 
with ADHD comorbidity? 
Dependent 
STP point system 
Rate of change 
Independent 
Gender 
Linear Mixed Effects 
Methods 
Are there age group differences in 
treatment outcomes with children 
diagnosed with ADHD comorbidity, 
who attend an intensive summer 
treatment program? 
Dependent 
STP point system 
Rate of change 
Independent 
Comorbidity Types 
Age group 
Linear Mixed Effects 
Methods 
Do children with different comorbid 
diagnoses and ADHD, who attend an 
intensive summer treatment program, 
differ in treatment outcomes? 
Dependent 
STP point system 
Rate of change 
Independent 
ADHDType 
Linear Mixed Effects 
Methods 
 
 
132 
APPENDIX D 
 
TABLES OF MODEL SUMMARY FOR TOTAL WEEKLY POINTS
133 
APPENDIX D 
TABLES OF MODEL SUMMARY FOR TOTAL WEEKLY POINTS 
Model Summary for Total Weekly Points (Anxiety Comorbidity).  
Factor  Level  Beta  
95% Confidence 
Interval  
T  
P-value 
(T)  
(Intercept)  
 
-677.0  (-5139.07, 3784.96)  
-
0.30  
0.77  
Anxiety D/O, OCD, 
PTSD  
Yes vs. No  -734.3  (-2613.69, 1145.16)  
-
0.77  
0.44  
Week/time  3 vs. 2  443.9  (-294.25, 1182.16)  1.18  0.24  
 
4 vs. 2  1325.8  (595.32, 2056.18)  3.56  < 0.001  
 
5 vs. 2  1250.2  (515.8, 1984.63)  3.34  < 0.001  
 
6 vs. 2  1856.7  (1117.25, 2596.07)  4.93  < 0.001  
Age  
 
2505.1  (1096.87, 3913.27)  3.49  < 0.001  
Race  Other vs. Caucasian  492.2  (-1142.59, 2127)  0.59  0.55  
Gender  Male vs. Female  
-
1389.5  
(-3143.41, 364.44)  
-
1.55  
0.12  
 
  
Model Summary for Total Weekly Points (Mood Comorbidity).  
Factor  Level  Beta  95% Confidence Interval  T  P-value (T)  
(Intercept)  
 
-1000.8  (-5340.23, 3338.58)  -0.45  0.65  
Mood  Yes vs. No  -394.4  (-2366.29, 1577.4)  -0.39  0.69  
Week/time  3 vs. 2  641.8  (-126.29, 1409.86)  1.64  0.10  
 
4 vs. 2  1583.8  (825.33, 2342.2)  4.10  < 0.001  
 
5 vs. 2  1576.9  (817.24, 2336.56)  4.07  < 0.001  
 
6 vs. 2  2103.6  (1335.49, 2871.75)  5.37  < 0.001  
Age  
 
832.2  (380.1, 1284.38)  3.61  < 0.001  
Race  Other vs. Caucasian  319.9  (-1323.97, 1963.83)  0.38  0.70  
Gender  Male vs. Female  -1126.4  (-2917.8, 665.06)  -1.23  0.22  
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Model Summary for Total Weekly Points (Oppositional Defiance Disorder).  
Factor  Level  Beta  95% Confidence Interval  T  P-value (T)  
(Intercept)  
 
-3031.82  (-7698.38, 1634.74)  -1.27  0.20  
ODD  Yes vs. No  -2048.70  (-4015.76, -81.64)  -2.04  0.041  
Week/time  3 vs. 2  394.02  (-432.61, 1220.65)  0.94  0.35  
 
4 vs. 2  1065.70  (246.5, 1884.89)  2.55  0.011  
 
5 vs. 2  1142.91  (322.44, 1963.39)  2.73  0.006  
 
6 vs. 2  1574.41  (745.16, 2403.66)  3.73  < 0.001  
Age  
 
1085.31  (597.6, 1573.01)  4.37  < 0.001  
Race  Other vs. Caucasian  34.92  (-1705.14, 1774.97)  0.04  0.97  
Gender  Male vs. Female  -655.06  (-2569.95, 1259.82)  -0.67  0.50  
 
 
 
Model Summary for Total Weekly Points (PDD, aspergers, autism spectrum).  
Factor  Level  Beta  
95% 
Confidence 
Interval  
T  
P-value 
(T)  
(Intercept)  
 
-1339.2  
(-5831.16, 
3152.66)  
-0.59  0.56  
PDD, aspergers, 
autism spectrum  
Yes vs. No  -1145.0  
(-3524.84, 
1234.86)  
-0.94  0.35  
Week/time  3 vs. 2  653.1  
(-142.4, 
1448.55)  
1.61  0.11  
 
4 vs. 2  1468.6  
(681.03, 
2256.2)  
3.66  < 0.001  
 
5 vs. 2  1497.8  
(707.6, 
2288.05)  
3.72  < 0.001  
 
6 vs. 2  1959.4  
(1159.77, 
2759.07)  
4.81  < 0.001  
Age  
 
885.9  
(421.5, 
1350.34)  
3.74  < 0.001  
Race  Other vs. Caucasian  542.3  
(-1268.56, 
2353.11)  
0.59  0.56  
Gender  Male vs. Female  -1278.7  
(-3223.95, 
666.52)  
-1.29  0.20  
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Model Summary for Total Weekly Points (Tic-Tourettes Comorbidity).  
Factor  Level  Beta  95% Confidence Interval  T  P-value (T)  
(Intercept)  
 
-574.8  (-5166.07, 4016.42)  -0.25  0.81  
Tic-Tourettes  Yes vs. No  532.2  (-1969.45, 3033.85)  0.42  0.68  
Week/time  3 vs. 2  507.1  (-312.37, 1326.63)  1.21  0.22  
 
4 vs. 2  1428.2  (618.38, 2237.94)  3.46  < 0.001  
 
5 vs. 2  1543.2  (732.06, 2354.45)  3.73  < 0.001  
 
6 vs. 2  1982.2  (1161.25, 2803.26)  4.74  < 0.001  
Age  
 
783.8  (306.48, 1261.08)  3.22  0.001  
Race  Other vs. Caucasian  550.0  (-1221.66, 2321.62)  0.61  0.54  
Gender  Male vs. Female  -1134.2  (-3062.67, 794.25)  -1.15  0.25  
 
 
 
 
Model Summary for Total Weekly Points (Learning Disorder Comorbidity).  
Factor  Level  Beta  95% Confidence Interval  T  P-value (T)  
(Intercept)  
 
-1125.6  (-5347.38, 3096.27)  -0.52  0.60  
Learning disorder  Yes vs. No  884.0  (-924.06, 2692.02)  0.96  0.34  
Week/time  3 vs. 2  508.3  (-236.82, 1253.35)  1.34  0.18  
 
4 vs. 2  1294.0  (559.18, 2028.9)  3.46  < 0.001  
 
5 vs. 2  1554.4  (818.39, 2290.41)  4.14  < 0.001  
 
6 vs. 2  2054.4  (1310.46, 2798.38)  5.42  < 0.001  
Age  
 
860.2  (424.04, 1296.47)  3.87  < 0.001  
Race  Other vs. Caucasian  546.8  (-1004.09, 2097.76)  0.69  0.49  
Gender  Male vs. Female  -1234.0  (-2931.34, 463.35)  -1.43  0.15  
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Model Summary for Total Weekly Points (Number of comorbidities).  
Factor  Level  Beta  SE  
95% 
Confidence 
Interval  
T  
P-value 
(T)  
(Intercept)  
 
-0.07  1808.9  
(-3547.96, 
3547.81)  
0.00  > 0.99  
Number of 
Comorbidities  
1 vs. 0  -358.02  669.7  
(-1671.58, 
955.53)  
-0.53  0.59  
 
2 vs. 0  -189.46  1098.0  
(-2342.99, 
1964.08)  
-0.17  0.86  
 
3 vs. 0  -843.59  1544.8  
(-3873.62, 
2186.44)  
-0.55  0.59  
Week/time  3 vs. 2  793.00  296.7  
(211.11, 
1374.89)  
2.67  0.008  
 
4 vs. 2  1419.20  293.2  
(844.2, 
1994.19)  
4.84  < 0.001  
 
5 vs. 2  1735.13  294.1  
(1158.26, 
2312.01)  
5.90  < 0.001  
 
6 vs. 2  2177.07  295.3  
(1597.86, 
2756.28)  
7.37  < 0.001  
Age  
 
755.80  183.6  
(395.65, 
1115.95)  
4.12  < 0.001  
Race  Other vs. Caucasian  -126.02  682.8  
(-1465.21, 
1213.16)  
-0.18  0.85  
Gender  Male vs. Female  -1482.08  749.0  
(-2951.06, -
13.09)  
-1.98  0.048  
 
